| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Ablative fractional laser-assisted treatments for keratinocyte carcinomas and its precursors–Clinical review and future perspectives
|
Erlendsson, Andrés M.
|
|
|
79-80 |
C |
p. 185-194
|
article
|
| 2 |
A brief history of long circulating nanoparticles
|
Haroon, H.B.
|
|
|
79-80 |
C |
p.
|
article
|
| 3 |
Absorption, distribution, metabolism and excretion of the biomaterials used in Nanocarrier drug delivery systems
|
Su, Chong
|
|
|
79-80 |
C |
p. 97-114
|
article
|
| 4 |
A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos
|
Rankin-Turner, Stephanie
|
|
|
79-80 |
C |
p. 479-491
|
article
|
| 5 |
Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy
|
Woodsong, Cynthia
|
|
2015
|
79-80 |
C |
p. 146-154
9 p.
|
article
|
| 6 |
Acellular and cellular approaches to improve diabetic wound healing
|
Cho, Hongkwan
|
|
2019
|
79-80 |
C |
p. 267-288
|
article
|
| 7 |
Acellular matrix in urethral reconstruction
|
Ribeiro-Filho, Leopoldo Alves
|
|
2015
|
79-80 |
C |
p. 38-46
9 p.
|
article
|
| 8 |
A comprehensive comparison of DNA and RNA vaccines
|
Wang, Chunxi
|
|
|
79-80 |
C |
p.
|
article
|
| 9 |
Acoustic behavior of microbubbles and implications for drug delivery
|
Kooiman, Klazina
|
|
2014
|
79-80 |
C |
p. 28-48
21 p.
|
article
|
| 10 |
AcousticRobots: Smart acoustically powered micro-/nanoswimmers for precise biomedical applications
|
Wu, Gege
|
|
|
79-80 |
C |
p.
|
article
|
| 11 |
Acoustic tweezers for targeted drug delivery
|
Guerassimoff, Léa
|
|
|
79-80 |
C |
p.
|
article
|
| 12 |
Activatable dual-functional molecular agents for imaging-guided cancer therapy
|
Zhang, Peng
|
|
|
79-80 |
C |
p.
|
article
|
| 13 |
Activatable fluorescence: From small molecule to nanoparticle
|
Luby, Benjamin M.
|
|
2017
|
79-80 |
C |
p. 97-121
25 p.
|
article
|
| 14 |
Activatable fluorescent probes for real-time imaging-guided tumor therapy
|
Duan, Qi-Jia
|
|
|
79-80 |
C |
p.
|
article
|
| 15 |
Adaptive immune responses to SARS-CoV-2
|
Forthal, Donald
|
|
|
79-80 |
C |
p. 1-8
|
article
|
| 16 |
Additive manufacturing in drug delivery: Innovative drug product design and opportunities for industrial application
|
Ragelle, Héloïse
|
|
|
79-80 |
C |
p.
|
article
|
| 17 |
Additive manufacturing in respiratory sciences – Current applications and future prospects
|
Bock, Simon
|
|
|
79-80 |
C |
p.
|
article
|
| 18 |
ADDR Editor’s Collection 2015
|
Ghandehari, Hamidreza
|
|
2015
|
79-80 |
C |
p. 1-2
2 p.
|
article
|
| 19 |
ADDR Editor’s Collection 2017
|
Ghandehari, Hamidreza
|
|
2017
|
79-80 |
C |
p. 1
|
article
|
| 20 |
ADDR Editor’s Collection 2018
|
Ghandehari, Hamidreza
|
|
2018
|
79-80 |
C |
p. 1
|
article
|
| 21 |
ADDR Editor's Collection 2019
|
Ghandehari, Hamidreza
|
|
|
79-80 |
C |
p. 1
|
article
|
| 22 |
Addressing barriers to effective cancer immunotherapy with nanotechnology: achievements, challenges, and roadmap to the next generation of nanoimmunotherapeutics
|
Hong, Enping
|
|
2019
|
79-80 |
C |
p. 3-22
|
article
|
| 23 |
Addressing the in vivo delivery of nucleic-acid nanostructure therapeutics
|
Alexander, Shana
|
|
|
79-80 |
C |
p.
|
article
|
| 24 |
Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications
|
Ye, Dezhuang
|
|
|
79-80 |
C |
p.
|
article
|
| 25 |
Adenosine and lipids: A forced marriage or a love match?
|
Rouquette, Marie
|
|
|
79-80 |
C |
p. 233-244
|
article
|
| 26 |
Adherence to minimal experimental requirements for defining extracellular vesicles and their functions
|
Poupardin, Rodolphe
|
|
|
79-80 |
C |
p.
|
article
|
| 27 |
Advanced delivery systems for peptide antibiotics
|
Cesaro, Angela
|
|
|
79-80 |
C |
p.
|
article
|
| 28 |
Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications
|
Maharjan, Sushila
|
|
|
79-80 |
C |
p.
|
article
|
| 29 |
Advanced drug delivery 2020 and beyond: Perspectives on the future
|
Bae, You Han
|
|
|
79-80 |
C |
p. 4-16
|
article
|
| 30 |
Advanced drug delivery 2020 - Parts 1, 2 and 3
|
Ghandehari, H.
|
|
|
79-80 |
C |
p. 1-2
|
article
|
| 31 |
Advanced drug delivery systems and artificial skin grafts for skin wound healing
|
Kim, Hye Sung
|
|
2019
|
79-80 |
C |
p. 209-239
|
article
|
| 32 |
Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites
|
Cao, Jun
|
|
|
79-80 |
C |
p. 170-188
|
article
|
| 33 |
Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics
|
Artzy-Schnirman, Arbel
|
|
|
79-80 |
C |
p.
|
article
|
| 34 |
Advanced imaging techniques for tracking drug dynamics at the subcellular level
|
Zhang, Chengying
|
|
|
79-80 |
C |
p.
|
article
|
| 35 |
Advanced in vitro models of vascular biology: Human induced pluripotent stem cells and organ-on-chip technology
|
Cochrane, Amy
|
|
2019
|
79-80 |
C |
p. 68-77
|
article
|
| 36 |
Advanced light delivery materials and systems for photomedicines
|
Kim, Seong-Jong
|
|
|
79-80 |
C |
p.
|
article
|
| 37 |
Advanced methodologies for cocrystal synthesis
|
Douroumis, Dennis
|
|
2017
|
79-80 |
C |
p. 178-195
18 p.
|
article
|
| 38 |
Advanced microbiome therapeutics for oral delivery of peptides and proteins: Advances, challenges, and opportunities
|
Gelli, Hitesh P.
|
|
|
79-80 |
C |
p.
|
article
|
| 39 |
Advanced nanomedicines for the treatment of inflammatory diseases
|
Brusini, Romain
|
|
|
79-80 |
C |
p. 161-178
|
article
|
| 40 |
Advanced nanotherapies to promote neuroregeneration in the injured newborn brain
|
Arteaga Cabeza, Olatz
|
|
|
79-80 |
C |
p. 19-37
|
article
|
| 41 |
Advanced optical imaging for the rational design of nanomedicines
|
Ortiz-Perez, Ana
|
|
|
79-80 |
C |
p.
|
article
|
| 42 |
Advancedoral vaccine delivery strategies for improving the immunity
|
Zhang, Yuandong
|
|
|
79-80 |
C |
p.
|
article
|
| 43 |
Advanced structural characterisation of pharmaceuticals using nano-thermal analysis (nano-TA)
|
Goh, Choon Fu
|
|
|
79-80 |
C |
p.
|
article
|
| 44 |
Advanced theragnostics for the central nervous system (CNS) and neurological disorders using functional inorganic nanomaterials
|
Conklin, Brandon
|
|
|
79-80 |
C |
p.
|
article
|
| 45 |
Advanced vaccine delivery
|
Ma, Guanghui
|
|
|
79-80 |
C |
p.
|
article
|
| 46 |
Advancement in integrin facilitated drug delivery
|
Arosio, Daniela
|
|
2016
|
79-80 |
C |
p. 111-143
33 p.
|
article
|
| 47 |
Advancements in brachytherapy
|
Tanderup, Kari
|
|
2017
|
79-80 |
C |
p. 15-25
11 p.
|
article
|
| 48 |
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics
|
Kang, Diana D.
|
|
|
79-80 |
C |
p.
|
article
|
| 49 |
Advances and controversies in studying sunscreen delivery and toxicity
|
Yamada, Miko
|
|
|
79-80 |
C |
p. 72-86
|
article
|
| 50 |
Advances and future perspectives in epithelial drug delivery
|
Mohammed, Yousuf
|
|
|
79-80 |
C |
p.
|
article
|
| 51 |
Advances and hurdles to clinical translation of RNAi therapeutics
|
Kwon, Ick Chan
|
|
2016
|
79-80 |
C |
p. 1-
1 p.
|
article
|
| 52 |
Advances and new technologies in the treatment of burn injury
|
Wang, Yiwei
|
|
2018
|
79-80 |
C |
p. 1-2
|
article
|
| 53 |
Advances, challenges, and future directions in the clinical translation of ECM biomaterials for regenerative medicine applications
|
Capella-Monsonís, Héctor
|
|
|
79-80 |
C |
p.
|
article
|
| 54 |
Advances in bacteria-based therapy for drug delivery
|
Liu, Jinyao
|
|
|
79-80 |
C |
p.
|
article
|
| 55 |
Advances in biocompatibility and physico-chemical characterization of microspheres for cell encapsulation
|
Rokstad, Anne Mari A.
|
|
2014
|
79-80 |
C |
p. 111-130
20 p.
|
article
|
| 56 |
Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring
|
Lifson, Mark A.
|
|
|
79-80 |
C |
p. 90-104
|
article
|
| 57 |
Advances in cancer stem cell targeting: How to strike the evil at its root
|
Pützer, Brigitte M.
|
|
2017
|
79-80 |
C |
p. 89-107
|
article
|
| 58 |
Advances in carbon nanomaterials and their polymeric composites in neural tissue engineering
|
Kanjilal, Baishali
|
|
|
79-80 |
C |
p.
|
article
|
| 59 |
Advances in computationally modeling human oral bioavailability
|
Wang, Junmei
|
|
2015
|
79-80 |
C |
p. 11-16
6 p.
|
article
|
| 60 |
Advances in development of exosomes for ophthalmic therapeutics
|
Tian, Ying
|
|
|
79-80 |
C |
p.
|
article
|
| 61 |
Advances in drug delivery for women’s health: A matter of gender equity
|
das Neves, José
|
|
|
79-80 |
C |
p.
|
article
|
| 62 |
Advances in enhancing photoprotection of sunscreens using hydrocarbon film formers and carbon nanomaterials
|
Addae, Ajoa J.
|
|
|
79-80 |
C |
p.
|
article
|
| 63 |
Advances in gene-based vaccine platforms to address the COVID-19 pandemic
|
Pushparajah, Deborah
|
|
|
79-80 |
C |
p. 113-141
|
article
|
| 64 |
Advances in genome editing for genetic hearing loss
|
Ding, Ning
|
|
|
79-80 |
C |
p. 118-133
|
article
|
| 65 |
Advances in image-guided drug delivery for antibacterial therapy
|
Huang, Haiyan
|
|
|
79-80 |
C |
p.
|
article
|
| 66 |
Advances in imaging probes and optical microendoscopic imaging techniques for early in vivo cancer assessment
|
Khemthongcharoen, Numfon
|
|
2014
|
79-80 |
C |
p. 53-74
22 p.
|
article
|
| 67 |
Advances in immunotherapy of type I diabetes
|
Ni, Qianqian
|
|
2019
|
79-80 |
C |
p. 83-91
|
article
|
| 68 |
Advances in keratinocyte delivery in burn wound care
|
ter Horst, Britt
|
|
2018
|
79-80 |
C |
p. 18-32
|
article
|
| 69 |
Advances in local drug delivery technologies for improved rheumatoid arthritis therapy
|
An, Xiaoran
|
|
|
79-80 |
C |
p.
|
article
|
| 70 |
Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention
|
Krovi, Sai Archana
|
|
|
79-80 |
C |
p.
|
article
|
| 71 |
Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection
|
Ullah Nayan, Mohammad
|
|
|
79-80 |
C |
p.
|
article
|
| 72 |
Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems
|
Maeki, Masatoshi
|
|
2018
|
79-80 |
C |
p. 84-100
|
article
|
| 73 |
Advances in modular control of CAR-T therapy with adapter-mediated CARs
|
McCue, Amelia C.
|
|
|
79-80 |
C |
p.
|
article
|
| 74 |
Advances in mRNA non-viral delivery approaches
|
Ibba, Maria L.
|
|
|
79-80 |
C |
p.
|
article
|
| 75 |
Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery
|
Han, Geonhee
|
|
|
79-80 |
C |
p.
|
article
|
| 76 |
Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss
|
Li, Lilun
|
|
2017
|
79-80 |
C |
p. 2-12
11 p.
|
article
|
| 77 |
Advances in nanoparticle mediated targeting of RNA binding protein for cancer
|
Kashikar, Rama
|
|
|
79-80 |
C |
p.
|
article
|
| 78 |
Advances in peptide-mediated cytosolic delivery of proteins
|
Sánchez-Navarro, Macarena
|
|
|
79-80 |
C |
p. 187-198
|
article
|
| 79 |
Advances in photoactivated carbon-based nanostructured materials for targeted cancer therapy
|
Eftekharifar, Maryam
|
|
|
79-80 |
C |
p.
|
article
|
| 80 |
Advances in powder bed fusion 3D printing in drug delivery and healthcare
|
Awad, Atheer
|
|
|
79-80 |
C |
p. 406-424
|
article
|
| 81 |
Advances in Salmonella Typhimurium-based drug delivery system for cancer therapy
|
Chen, Wenfei
|
|
|
79-80 |
C |
p.
|
article
|
| 82 |
Advances in Single-component inorganic nanostructures for photoacoustic imaging guided photothermal therapy
|
Zhu, Houjuan
|
|
|
79-80 |
C |
p.
|
article
|
| 83 |
Advances in solid formulation of pharmaceutical biologics
|
(Tony) Zhou, Qi
|
|
|
79-80 |
C |
p.
|
article
|
| 84 |
Advances in the design and delivery of RNA vaccines for infectious diseases
|
Lokras, Abhijeet Girish
|
|
|
79-80 |
C |
p.
|
article
|
| 85 |
Advances in the development of antimicrobial peptides and proteins for inhaled therapy
|
Wang, Yuncheng
|
|
|
79-80 |
C |
p.
|
article
|
| 86 |
Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems
|
Hadji, Hicheme
|
|
|
79-80 |
C |
p.
|
article
|
| 87 |
Advances in transdermal insulin delivery
|
Zhang, Yuqi
|
|
2019
|
79-80 |
C |
p. 51-70
|
article
|
| 88 |
Advances of bacteria-based delivery systems for modulating tumor microenvironment
|
Li, Shuping
|
|
|
79-80 |
C |
p.
|
article
|
| 89 |
Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages
|
Yu, Wenqi
|
|
|
79-80 |
C |
p.
|
article
|
| 90 |
Advances on colorectal cancer 3D models: The needed translational technology for nanomedicine screening
|
Castro, Flávia
|
|
|
79-80 |
C |
p.
|
article
|
| 91 |
Advances on erythrocyte-mimicking nanovehicles to overcome barriers in biological microenvironments
|
Castro, Flávia
|
|
|
79-80 |
C |
p. 312-339
|
article
|
| 92 |
Advances on non-invasive physically triggered nucleic acid delivery from nanocarriers
|
Do, Hai Doan
|
|
2019
|
79-80 |
C |
p. 3-17
|
article
|
| 93 |
Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade
|
Choi, Youngjin
|
|
|
79-80 |
C |
p.
|
article
|
| 94 |
Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin
|
Shah, Shrey A.
|
|
|
79-80 |
C |
p.
|
article
|
| 95 |
Advancing pharmacy and healthcare with virtual digital technologies
|
Trenfield, Sarah J.
|
|
|
79-80 |
C |
p.
|
article
|
| 96 |
Advancing the cellular and molecular therapy for intervertebral disc disease
|
Sakai, Daisuke
|
|
2015
|
79-80 |
C |
p. 159-171
13 p.
|
article
|
| 97 |
Advancing tumor microenvironment and lymphoid tissue research through 3D bioprinting and biofabrication
|
Mazzaglia, Corrado
|
|
|
79-80 |
C |
p.
|
article
|
| 98 |
Aerosol pulmonary immune engineering
|
Sudduth, Emma R.
|
|
|
79-80 |
C |
p.
|
article
|
| 99 |
Aggregation-induced emission (AIE) fluorophores as imaging tools to trace the biological fate of nano-based drug delivery systems
|
Wang, Yufei
|
|
|
79-80 |
C |
p. 161-176
|
article
|
| 100 |
Aggregation-induced emission (AIE)-guided dynamic assembly for disease imaging and therapy
|
Wang, He-Ping
|
|
|
79-80 |
C |
p.
|
article
|
| 101 |
Agony of choice: How anesthetics affect the composition and function of extracellular vesicles
|
Abel, Frederik
|
|
|
79-80 |
C |
p.
|
article
|
| 102 |
A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics
|
Ranjbar, Sheyda
|
|
|
79-80 |
C |
p.
|
article
|
| 103 |
Air-Liquid interface cultures to model drug delivery through the mucociliary epithelial barrier
|
Lee, Rhianna E
|
|
|
79-80 |
C |
p.
|
article
|
| 104 |
Alginate biomaterial for the treatment of myocardial infarction: Progress, translational strategies, and clinical outlook
|
Ruvinov, Emil
|
|
2016
|
79-80 |
C |
p. 54-76
23 p.
|
article
|
| 105 |
Allergen to asset: Pollen-based drug delivery systems
|
Ibrahim, Mohammed Shahrudin
|
|
|
79-80 |
C |
p.
|
article
|
| 106 |
Altered peripheral factors affecting the absorption, distribution, metabolism, and excretion of oral medicines in Alzheimer’s disease
|
Waller, Elka S.
|
|
|
79-80 |
C |
p.
|
article
|
| 107 |
A minimalist's approach for DNA nanoconstructions
|
Zuo, Hua
|
|
|
79-80 |
C |
p. 22-28
|
article
|
| 108 |
α-Amino acid N-carboxyanhydride (NCA)-derived synthetic polypeptides for nucleic acids delivery
|
Liu, Yong
|
|
|
79-80 |
C |
p. 139-163
|
article
|
| 109 |
A moderate thermal dose is sufficient for effective free and TSL based thermochemotherapy
|
van Rhoon, G.C.
|
|
|
79-80 |
C |
p. 145-156
|
article
|
| 110 |
Amorphous Pharmaceutical Solids
|
Descamps, Marc
|
|
2016
|
79-80 |
C |
p. 1-2
2 p.
|
article
|
| 111 |
Amorphous powders for inhalation drug delivery
|
Chen, Lan
|
|
2016
|
79-80 |
C |
p. 102-115
14 p.
|
article
|
| 112 |
Amorphous solid dispersions: Rational selection of a manufacturing process
|
Vasconcelos, Teófilo
|
|
2016
|
79-80 |
C |
p. 85-101
17 p.
|
article
|
| 113 |
An emerging focus on lipids in extracellular vesicles
|
Skotland, Tore
|
|
|
79-80 |
C |
p. 308-321
|
article
|
| 114 |
An EPR-Independent extravasation Strategy: Deformable leukocytes as vehicles for improved solid tumor therapy
|
Wu, Huayu
|
|
|
79-80 |
C |
p.
|
article
|
| 115 |
A new chapter in pharmaceutical manufacturing: 3D-printed drug products
|
Norman, James
|
|
2017
|
79-80 |
C |
p. 39-50
12 p.
|
article
|
| 116 |
A new era in brain drug delivery: Integrating multivalency and computational optimisation for blood–brain barrier permeation
|
Porro, Giulia
|
|
|
79-80 |
C |
p.
|
article
|
| 117 |
A new era in posterior segment ocular drug delivery: Translation of systemic, cell-targeted, dendrimer-based therapies
|
Kannan, Rangaramanujam M.
|
|
|
79-80 |
C |
p.
|
article
|
| 118 |
A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines
|
Turuvekere Vittala Murthy, Namratha
|
|
|
79-80 |
C |
p.
|
article
|
| 119 |
Angiogenesis regulation by nanocarriers bearing RNA interference
|
Ofek, Paula
|
|
2017
|
79-80 |
C |
p. 3-19
|
article
|
| 120 |
Animal models for analysis of immunological responses to nanomaterials: Challenges and considerations
|
Zamboni, William C.
|
|
2018
|
79-80 |
C |
p. 82-96
|
article
|
| 121 |
Animal models of smoke inhalation injury and related acute and chronic lung diseases
|
Reczyńska, Katarzyna
|
|
2018
|
79-80 |
C |
p. 107-134
|
article
|
| 122 |
An integrated perspective for the diagnosis and therapy of neurodevelopmental disorders – From an engineering point of view
|
Mintz Hemed, Nofar
|
|
|
79-80 |
C |
p.
|
article
|
| 123 |
An old problem with new solutions: Strategies to improve vaccine efficacy in the elderly
|
Bell, Matthew R.
|
|
|
79-80 |
C |
p.
|
article
|
| 124 |
A novel platform for cancer therapy using extracellular vesicles
|
Tominaga, Naoomi
|
|
2015
|
79-80 |
C |
p. 50-55
6 p.
|
article
|
| 125 |
An overview of in vitro 3D models of the blood-brain barrier as a tool to predict the in vivo permeability of nanomedicines
|
Pérez-López, Alexandre
|
|
|
79-80 |
C |
p.
|
article
|
| 126 |
An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers
|
Xu, Yining
|
|
|
79-80 |
C |
p.
|
article
|
| 127 |
An overview of microRNAs
|
Hammond, Scott M.
|
|
2015
|
79-80 |
C |
p. 3-14
12 p.
|
article
|
| 128 |
An RNAi therapeutic, DFP-10825, for intraperitoneal and intrapleural malignant cancers
|
Ando, Hidenori
|
|
|
79-80 |
C |
p. 27-36
|
article
|
| 129 |
Anti-aging properties of phytoconstituents and phyto-nanoemulsions and their application in managing aging-related diseases
|
Xue, Feng
|
|
|
79-80 |
C |
p.
|
article
|
| 130 |
Antibiotic-containing polymers for localized, sustained drug delivery
|
Stebbins, Nicholas D.
|
|
2014
|
79-80 |
C |
p. 77-87
11 p.
|
article
|
| 131 |
Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy
|
Hutmacher, Cornelia
|
|
2019
|
79-80 |
C |
p. 67-91
|
article
|
| 132 |
Antibody Directed Enzyme Prodrug Therapy (ADEPT): Trials and tribulations
|
Sharma, Surinder K.
|
|
2017
|
79-80 |
C |
p. 2-7
|
article
|
| 133 |
Antibody-drug conjugates as multimodal therapies against hard-to-treat cancers
|
Armstrong, Georgina B
|
|
|
79-80 |
C |
p.
|
article
|
| 134 |
Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment
|
Zhang, Jing
|
|
|
79-80 |
C |
p. 245-273
|
article
|
| 135 |
Antifibrotic strategies for medical devices
|
Welch, Nicholas G.
|
|
|
79-80 |
C |
p. 109-120
|
article
|
| 136 |
Antifungal therapy: Novel drug delivery strategies driven by new targets
|
Wu, Shuang
|
|
|
79-80 |
C |
p.
|
article
|
| 137 |
Antimicrobial blue light: A ‘Magic Bullet’ for the 21st century and beyond?
|
Leanse, Leon G.
|
|
|
79-80 |
C |
p.
|
article
|
| 138 |
Antimicrobial hydrogels: A new weapon in the arsenal against multidrug-resistant infections
|
Ng, Victor W.L.
|
|
2014
|
79-80 |
C |
p. 46-62
17 p.
|
article
|
| 139 |
Antimicrobial peptides towards clinical application: Delivery and formulation
|
Wang, Cheng
|
|
|
79-80 |
C |
p.
|
article
|
| 140 |
Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients
|
Ciofu, Oana
|
|
2015
|
79-80 |
C |
p. 7-23
17 p.
|
article
|
| 141 |
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
|
Kozma, Gergely Tibor
|
|
|
79-80 |
C |
p. 163-175
|
article
|
| 142 |
Antisense oligonucleotides in therapy for neurodegenerative disorders
|
Evers, Melvin M.
|
|
2015
|
79-80 |
C |
p. 90-103
14 p.
|
article
|
| 143 |
Anti-thrombotic technologies for medical devices
|
Lavery, Karen S.
|
|
2017
|
79-80 |
C |
p. 2-11
10 p.
|
article
|
| 144 |
Application of advances in endocytosis and membrane trafficking to drug delivery
|
Ju, Yaping
|
|
|
79-80 |
C |
p. 118-141
|
article
|
| 145 |
Application of aptamers for in vivo molecular imaging and theranostics
|
Bouvier-Müller, Alix
|
|
2018
|
79-80 |
C |
p. 94-106
|
article
|
| 146 |
Application of cell encapsulation for controlled delivery of biological therapeutics
|
Orive, G.
|
|
2014
|
79-80 |
C |
p. 3-14
12 p.
|
article
|
| 147 |
Application of colloidal photonic crystals in study of organoids
|
Huang, Kai
|
|
|
79-80 |
C |
p.
|
article
|
| 148 |
Application of Förster Resonance Energy Transfer (FRET) technique to elucidate intracellular and In Vivo biofate of nanomedicines
|
Chen, Tongkai
|
|
|
79-80 |
C |
p. 177-205
|
article
|
| 149 |
Application of MIDD to accelerate the development of anti-infectives: Current status and future perspectives
|
Mak, Wen Yao
|
|
|
79-80 |
C |
p.
|
article
|
| 150 |
Application of super-resolution microscopy in mitochondria-dynamic diseases
|
Zou, Weiwei
|
|
|
79-80 |
C |
p.
|
article
|
| 151 |
Application of UV dissolution imaging to pharmaceutical systems
|
Brown, Benedict
|
|
|
79-80 |
C |
p.
|
article
|
| 152 |
Applications of AFM-IR for drug delivery vector characterization: infrared, thermal, and mechanical characterization at the nanoscale
|
Zhang, Jing
|
|
|
79-80 |
C |
p.
|
article
|
| 153 |
Applications of DNA-based nanostructures in immunotherapy
|
Li, Dandan
|
|
|
79-80 |
C |
p.
|
article
|
| 154 |
Applications of focused ultrasound-mediated blood-brain barrier opening
|
Gorick, Catherine M.
|
|
|
79-80 |
C |
p.
|
article
|
| 155 |
Applications of pharmacometrics in drug development
|
Xiong, Yuan
|
|
|
79-80 |
C |
p.
|
article
|
| 156 |
Applications of Raman spectroscopy in skin research — From skin physiology and diagnosis up to risk assessment and dermal drug delivery
|
Franzen, Lutz
|
|
2015
|
79-80 |
C |
p. 91-104
14 p.
|
article
|
| 157 |
Applying nanomedicine in maladaptive inflammation and angiogenesis
|
Alaarg, Amr
|
|
2017
|
79-80 |
C |
p. 143-158
|
article
|
| 158 |
Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment
|
Pinel, Sophie
|
|
2019
|
79-80 |
C |
p. 344-357
|
article
|
| 159 |
Approaches to surface engineering of extracellular vesicles
|
Richter, Maximilian
|
|
|
79-80 |
C |
p. 416-426
|
article
|
| 160 |
A proposed mathematical description of in vivo nanoparticle delivery
|
Wu, Jamie L.Y.
|
|
|
79-80 |
C |
p.
|
article
|
| 161 |
Aptamer-based applications in delivering cancer gene therapies and beyond: state of the art and the missing links to clinical translation
|
Coppola, Gabriele
|
|
|
79-80 |
C |
p.
|
article
|
| 162 |
Aptamer-based targeted therapy
|
Zhu, Guizhi
|
|
2018
|
79-80 |
C |
p. 65-78
|
article
|
| 163 |
Aptamer chemistry
|
Röthlisberger, Pascal
|
|
2018
|
79-80 |
C |
p. 3-21
|
article
|
| 164 |
Aptamer-guided nanomedicines for anticancer drug delivery
|
Alshaer, Walhan
|
|
2018
|
79-80 |
C |
p. 122-137
|
article
|
| 165 |
Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers
|
Zhou, Gang
|
|
2018
|
79-80 |
C |
p. 107-121
|
article
|
| 166 |
Aptamers in Therapeutics and Drug Delivery
|
Fattal, Elias
|
|
2018
|
79-80 |
C |
p. 1-2
|
article
|
| 167 |
Aptamers: Uptake mechanisms and intracellular applications
|
Yoon, Sorah
|
|
2018
|
79-80 |
C |
p. 22-35
|
article
|
| 168 |
A quantitative view on multivalent nanomedicine targeting
|
Woythe, Laura
|
|
|
79-80 |
C |
p. 1-21
|
article
|
| 169 |
Are caveolae a cellular entry route for non-viral therapeutic delivery systems?
|
Rewatkar, Prarthana V.
|
|
2015
|
79-80 |
C |
p. 92-108
17 p.
|
article
|
| 170 |
A review of drug delivery systems for capsule endoscopy
|
Munoz, Fredy
|
|
2014
|
79-80 |
C |
p. 77-85
9 p.
|
article
|
| 171 |
A review of emerging technologies enabling improved solid oral dosage form manufacturing and processing
|
Sohail Arshad, Muhammad
|
|
|
79-80 |
C |
p.
|
article
|
| 172 |
A review of upper airway physiology relevant to the delivery and deposition of inhalation aerosols
|
Mekonnen, Taye
|
|
|
79-80 |
C |
p.
|
article
|
| 173 |
A review on core–shell structured unimolecular nanoparticles for biomedical applications
|
Chen, Guojun
|
|
2018
|
79-80 |
C |
p. 58-72
|
article
|
| 174 |
Articular fibrocartilage - Why does hyaline cartilage fail to repair?
|
Armiento, Angela R.
|
|
2019
|
79-80 |
C |
p. 289-305
|
article
|
| 175 |
Artificial intelligence and machine learning assisted drug delivery for effective treatment of infectious diseases
|
He, Sheng
|
|
|
79-80 |
C |
p.
|
article
|
| 176 |
Artificial intelligence to bring nanomedicine to life
|
Serov, Nikita
|
|
|
79-80 |
C |
p.
|
article
|
| 177 |
A slippery slope: On the origin, role and physiology of mucus
|
Taherali, Farhan
|
|
2018
|
79-80 |
C |
p. 16-33
|
article
|
| 178 |
A systematic overview of strategies for photosensitizer and light delivery in antibacterial photodynamic therapy for lung infections
|
Shleeva, Margarita O.
|
|
|
79-80 |
C |
p.
|
article
|
| 179 |
A Toll-like receptor 3 (TLR3) agonist ARNAX for therapeutic immunotherapy
|
Seya, Tsukasa
|
|
|
79-80 |
C |
p. 37-43
|
article
|
| 180 |
Automation and data-driven design of polymer therapeutics
|
Upadhya, Rahul
|
|
|
79-80 |
C |
p. 1-28
|
article
|
| 181 |
Autophagy in the cancer-immunity dialogue
|
Yamazaki, Takahiro
|
|
|
79-80 |
C |
p. 40-50
|
article
|
| 182 |
A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders
|
Samal, Juhi
|
|
|
79-80 |
C |
p. 68-145
|
article
|
| 183 |
Bacteria and bacterial derivatives as delivery carriers for immunotherapy
|
Kang, Sae-Ryung
|
|
|
79-80 |
C |
p.
|
article
|
| 184 |
Bacteria-based bioactive materials for cancer imaging and therapy
|
Chen, Ying
|
|
|
79-80 |
C |
p.
|
article
|
| 185 |
Bacterial extracellular vesicles: Understanding biology promotes applications as nanopharmaceuticals
|
Jahromi, Leila Pourtalebi
|
|
|
79-80 |
C |
p. 125-140
|
article
|
| 186 |
Bacterially mediated drug delivery and therapeutics: Strategies and advancements
|
Wu, Leyang
|
|
|
79-80 |
C |
p.
|
article
|
| 187 |
Bacterial membrane vesicles for vaccine applications
|
Krishnan, Nishta
|
|
|
79-80 |
C |
p.
|
article
|
| 188 |
Bacteriophage-based biomaterials for tissue regeneration
|
Cao, Binrui
|
|
2019
|
79-80 |
C |
p. 73-95
|
article
|
| 189 |
Bacteriophage interactions with mammalian tissue: Therapeutic applications
|
Huh, Haein
|
|
2019
|
79-80 |
C |
p. 4-17
|
article
|
| 190 |
Bacteriophage-mediated modulation of microbiota for diseases treatment
|
Zhang, Yu
|
|
|
79-80 |
C |
p.
|
article
|
| 191 |
Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases
|
Tao, Pan
|
|
2019
|
79-80 |
C |
p. 57-72
|
article
|
| 192 |
Basic biology and therapeutic implications of lncRNA
|
Khorkova, O.
|
|
2015
|
79-80 |
C |
p. 15-24
10 p.
|
article
|
| 193 |
Battle of GLP-1 delivery technologies
|
Yu, Minzhi
|
|
2018
|
79-80 |
C |
p. 113-130
|
article
|
| 194 |
BDDCS, the Rule of 5 and drugability
|
Benet, Leslie Z.
|
|
2016
|
79-80 |
C |
p. 89-98
10 p.
|
article
|
| 195 |
Be a GEM: Biocontained, environmentally applied, genetically engineered microbes
|
Moon, Tae Seok
|
|
|
79-80 |
C |
p.
|
article
|
| 196 |
Bench-to-bedside translation of dendrimers: Reality or utopia? A concise analysis
|
Mignani, Serge
|
|
2018
|
79-80 |
C |
p. 73-81
|
article
|
| 197 |
Beyond conventional antibiotics — New directions for combination products to combat biofilm
|
Bayramov, Danir Fanisovich
|
|
2017
|
79-80 |
C |
p. 48-60
13 p.
|
article
|
| 198 |
Beyond PEGylation: Alternative surface-modification of nanoparticles with mucus-inert biomaterials
|
Khutoryanskiy, Vitaliy V.
|
|
2018
|
79-80 |
C |
p. 140-149
|
article
|
| 199 |
Beyond the adverse effects of the systemic route: Exploiting nanocarriers for the topical treatment of skin cancers
|
da Silva Gomes, Beatriz
|
|
|
79-80 |
C |
p.
|
article
|
| 200 |
Beyond the borders — Biomedical applications of non-linear Raman microscopy
|
Winterhalder, Martin Josef
|
|
2015
|
79-80 |
C |
p. 135-144
10 p.
|
article
|
| 201 |
Bioactive 2D nanomaterials for neural repair and regeneration
|
He, Xiaolie
|
|
|
79-80 |
C |
p.
|
article
|
| 202 |
Bioactive lipids, inflammation and chronic diseases
|
Leuti, Alessandro
|
|
|
79-80 |
C |
p. 133-169
|
article
|
| 203 |
Bioactive scaffolds based on elastin-like materials for wound healing
|
Rodríguez-Cabello, J. Carlos
|
|
|
79-80 |
C |
p. 118-133
|
article
|
| 204 |
Biochemical studies on the structure–function relationship of major drug transporters in the ATP-binding cassette family and solute carrier family
|
Hong, Mei
|
|
2017
|
79-80 |
C |
p. 3-20
18 p.
|
article
|
| 205 |
Biocompatibility and safety of PLA and its copolymers
|
Ramot, Yuval
|
|
2016
|
79-80 |
C |
p. 153-162
|
article
|
| 206 |
Bioconjugates for targeted delivery of therapeutic oligonucleotides
|
Ming, Xin
|
|
2015
|
79-80 |
C |
p. 81-89
9 p.
|
article
|
| 207 |
Biodistribution, pharmacokinetics and excretion studies of intravenously injected nanoparticles and extracellular vesicles: Possibilities and challenges
|
Skotland, Tore
|
|
|
79-80 |
C |
p.
|
article
|
| 208 |
Bioengineered baculoviruses as new class of therapeutics using micro and nanotechnologies: Principles, prospects and challenges
|
Paul, Arghya
|
|
2014
|
79-80 |
C |
p. 115-130
16 p.
|
article
|
| 209 |
Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: So near and yet so far
|
Thanuja M.Y.,
|
|
2018
|
79-80 |
C |
p. 57-80
|
article
|
| 210 |
Bioengineered elastin- and silk-biomaterials for drug and gene delivery
|
Chambre, Laura
|
|
|
79-80 |
C |
p. 186-198
|
article
|
| 211 |
Bioengineered heparins and heparan sulfates
|
Fu, Li
|
|
2016
|
79-80 |
C |
p. 237-249
13 p.
|
article
|
| 212 |
Bioengineering 3D environments for cancer models
|
Alemany-Ribes, Mireia
|
|
2014
|
79-80 |
C |
p. 40-49
10 p.
|
article
|
| 213 |
Bioengineering methods for myocardial regeneration
|
Parsa, Hesam
|
|
2016
|
79-80 |
C |
p. 195-202
8 p.
|
article
|
| 214 |
Bioengineering of virus-like particles as dynamic nanocarriers for in vivo delivery and targeting to solid tumours
|
Suffian, Izzat F.B.M
|
|
|
79-80 |
C |
p.
|
article
|
| 215 |
Bioengineering strategies for inducing tolerance in autoimmune diabetes
|
Baekkeskov, Steinunn
|
|
2017
|
79-80 |
C |
p. 256-265
|
article
|
| 216 |
Bioengineering toolkits for potentiating organoid therapeutics
|
Park, Sewon
|
|
|
79-80 |
C |
p.
|
article
|
| 217 |
Bioequivalence assessment of pharmaceutical aerosol products through IVIVC
|
Sandell, Dennis
|
|
|
79-80 |
C |
p.
|
article
|
| 218 |
Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections
|
Subramaniam, Santhni
|
|
|
79-80 |
C |
p.
|
article
|
| 219 |
Biological and intracellular fates of drug nanocrystals through different delivery routes: Recent development enabled by bioimaging and PK modeling
|
Lv, Yongjiu
|
|
|
79-80 |
C |
p.
|
article
|
| 220 |
Biologics and their delivery systems: Trends in myocardial infarction
|
Borrelli, Matthew A.
|
|
|
79-80 |
C |
p. 181-215
|
article
|
| 221 |
Biologics for tendon repair
|
Docheva, Denitsa
|
|
2015
|
79-80 |
C |
p. 222-239
18 p.
|
article
|
| 222 |
Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer’s disease
|
Vandendriessche, Charysse
|
|
|
79-80 |
C |
p.
|
article
|
| 223 |
Biomarkers of spinal cord injury and ensuing bladder dysfunction
|
Cruz, Célia Duarte
|
|
2015
|
79-80 |
C |
p. 153-159
7 p.
|
article
|
| 224 |
Biomaterial-assisted macrophage cell therapy for regenerative medicine
|
Sung, Samuel
|
|
|
79-80 |
C |
p.
|
article
|
| 225 |
Biomaterial-based delivery for skeletal muscle repair
|
Cezar, Christine A.
|
|
2015
|
79-80 |
C |
p. 188-197
10 p.
|
article
|
| 226 |
Biomaterial-based delivery of nucleic acids for tissue regeneration
|
Zhuang, Yaping
|
|
|
79-80 |
C |
p.
|
article
|
| 227 |
Biomaterials based on phages and other viruses
|
Yang, Mingying
|
|
2019
|
79-80 |
C |
p. 1-3
|
article
|
| 228 |
Biomaterials releasing drug responsively to promote wound healing via regulation of pathological microenvironment
|
Li, Haisheng
|
|
|
79-80 |
C |
p.
|
article
|
| 229 |
Biomaterial strategies for engineering implants for enhanced osseointegration and bone repair
|
Agarwal, Rachit
|
|
2015
|
79-80 |
C |
p. 53-62
10 p.
|
article
|
| 230 |
Biomaterial strategies for generating therapeutic immune responses
|
Kelly, Sean H.
|
|
2017
|
79-80 |
C |
p. 3-18
|
article
|
| 231 |
Biomatrices for bladder reconstruction
|
Lin, Hsueh-Kung
|
|
2015
|
79-80 |
C |
p. 47-63
17 p.
|
article
|
| 232 |
Biomechanical conditioning of tissue engineered heart valves: Too much of a good thing?
|
Parvin Nejad, Shouka
|
|
2016
|
79-80 |
C |
p. 161-175
15 p.
|
article
|
| 233 |
Biomechanical forces in the skeleton and their relevance to bone metastasis: Biology and engineering considerations
|
Lynch, Maureen E.
|
|
2014
|
79-80 |
C |
p. 119-134
16 p.
|
article
|
| 234 |
Biomedical application of small extracellular vesicles in cancer treatment
|
Araujo-Abad, Salome
|
|
|
79-80 |
C |
p.
|
article
|
| 235 |
Biomedical applications of polymers derived by reversible addition – fragmentation chain-transfer (RAFT)
|
Fairbanks, Benjamin D.
|
|
2015
|
79-80 |
C |
p. 141-152
12 p.
|
article
|
| 236 |
Biomedical engineering of two-dimensional MXenes
|
Huang, Hui
|
|
|
79-80 |
C |
p.
|
article
|
| 237 |
Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles
|
Wang, Jing
|
|
|
79-80 |
C |
p.
|
article
|
| 238 |
Biomimetic approaches in bone tissue engineering: Integrating biological and physicomechanical strategies
|
Fernandez-Yague, Marc A.
|
|
2015
|
79-80 |
C |
p. 1-29
29 p.
|
article
|
| 239 |
Biomimetic immunomodulation strategies for effective tissue repair and restoration
|
Villarreal-Leal, Ramiro Alejandro
|
|
|
79-80 |
C |
p.
|
article
|
| 240 |
Biomimetic supramolecular designs for the controlled release of growth factors in bone regeneration
|
Azevedo, Helena S.
|
|
2015
|
79-80 |
C |
p. 63-76
14 p.
|
article
|
| 241 |
Bio-mimic particles for the enhanced vaccinations: Lessons learnt from the natural traits and pathogenic invasion
|
Wu, Sihua
|
|
|
79-80 |
C |
p.
|
article
|
| 242 |
Biopharmaceutical drug delivery and phototherapy using protein crystals
|
Zhou, Renbin
|
|
|
79-80 |
C |
p.
|
article
|
| 243 |
Biophotonics for diagnostic detection of extracellular vesicles
|
Gualerzi, Alice
|
|
|
79-80 |
C |
p. 229-249
|
article
|
| 244 |
Biophysical heterogeneity of myeloid-derived microenvironment to regulate resistance to cancer immunotherapy
|
Zhao, Jie
|
|
|
79-80 |
C |
p.
|
article
|
| 245 |
Bioreactor technologies to support liver function in vitro
|
Ebrahimkhani, Mohammad R.
|
|
2014
|
79-80 |
C |
p. 132-157
26 p.
|
article
|
| 246 |
Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives
|
Kotla, Niranjan G.
|
|
2019
|
79-80 |
C |
p. 248-266
|
article
|
| 247 |
Biosafety of mesoporous silica nanoparticles; towards clinical translation
|
Lérida-Viso, Araceli
|
|
|
79-80 |
C |
p.
|
article
|
| 248 |
Bio-synthetic materials for immunomodulation of islet transplants
|
Foster, Greg A.
|
|
2017
|
79-80 |
C |
p. 266-271
|
article
|
| 249 |
Bladder tissue engineering: A literature review
|
Lam Van Ba, Ornella
|
|
2015
|
79-80 |
C |
p. 31-37
7 p.
|
article
|
| 250 |
Blood-brain barrier delivery for lysosomal storage disorders with IgG-lysosomal enzyme fusion proteins
|
Pardridge, William M.
|
|
|
79-80 |
C |
p.
|
article
|
| 251 |
Blood-brain barrier models: Rationale for selection
|
Hanafy, Amira Sayed
|
|
|
79-80 |
C |
p.
|
article
|
| 252 |
Blood derivatives awaken in regenerative medicine strategies to modulate wound healing
|
Mendes, Bárbara B.
|
|
|
79-80 |
C |
p. 376-393
|
article
|
| 253 |
Brain metastasis models: What should we aim to achieve better treatments?
|
Masmudi-Martín, M.
|
|
|
79-80 |
C |
p. 79-99
|
article
|
| 254 |
Branched polyesters: Preparative strategies and applications
|
d'Arcy, Richard
|
|
2016
|
79-80 |
C |
p. 60-81
|
article
|
| 255 |
Breaking the final barrier: Evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome
|
Mrksich, Kaitlin
|
|
|
79-80 |
C |
p.
|
article
|
| 256 |
Breaking through the barrier: Modelling and exploiting the physical microenvironment to enhance drug transport and efficacy
|
Gładysz, Magdalena Z.
|
|
|
79-80 |
C |
p.
|
article
|
| 257 |
Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research
|
Viegas, Juliana
|
|
|
79-80 |
C |
p.
|
article
|
| 258 |
Bridging the gaps between academic research and industrial product developments of lipid-based formulations
|
Holm, René
|
|
2019
|
79-80 |
C |
p. 118-127
|
article
|
| 259 |
Brief update on endocytosis of nanomedicines
|
Patel, Siddharth
|
|
|
79-80 |
C |
p. 90-111
|
article
|
| 260 |
Bringing innovative wound care polymer materials to the market: Challenges, developments, and new trends
|
Sanjarnia, Pegah
|
|
|
79-80 |
C |
p.
|
article
|
| 261 |
Building the design, translation and development principles of polymeric nanomedicines using the case of clinically advanced poly(lactide(glycolide))–poly(ethylene glycol) nanotechnology as a model: An industrial viewpoint
|
Lakkireddy, Harivardhan Reddy
|
|
2016
|
79-80 |
C |
p. 289-332
|
article
|
| 262 |
Building three-dimensional lung models for studying pharmacokinetics of inhaled drugs
|
Barros, Andreia Sofia
|
|
|
79-80 |
C |
p. 386-395
|
article
|
| 263 |
Burn injury: Challenges and advances in burn wound healing, infection, pain and scarring
|
Wang, Yiwei
|
|
2018
|
79-80 |
C |
p. 3-17
|
article
|
| 264 |
Burn wound infections microbiome and novel approaches using therapeutic microorganisms in burn wound infection control
|
Maitz, J.
|
|
|
79-80 |
C |
p.
|
article
|
| 265 |
Caenorhabditis elegans as an emerging high throughput chronotherapeutic drug screening platform for human neurodegenerative disorders
|
Panda, Mrutyunjaya
|
|
|
79-80 |
C |
p.
|
article
|
| 266 |
Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting
|
Rimal, Rahul
|
|
|
79-80 |
C |
p.
|
article
|
| 267 |
Cancer nanotechnology
|
Grodzinski, Piotr
|
|
2014
|
79-80 |
C |
p. 1-
1 p.
|
article
|
| 268 |
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
|
Bertrand, Nicolas
|
|
2014
|
79-80 |
C |
p. 2-25
24 p.
|
article
|
| 269 |
Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments
|
Krause, Mechthild
|
|
2017
|
79-80 |
C |
p. 63-73
11 p.
|
article
|
| 270 |
Cancer stromal targeting therapy to overcome the pitfall of EPR effect
|
Matsumura, Yasuhiro
|
|
|
79-80 |
C |
p. 142-150
|
article
|
| 271 |
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies
|
Soetaert, Frederik
|
|
|
79-80 |
C |
p. 65-83
|
article
|
| 272 |
Candidiasis: From cutaneous to systemic, new perspectives of potential targets and therapeutic strategies
|
Lu, Hui
|
|
|
79-80 |
C |
p.
|
article
|
| 273 |
Can microorganisms develop resistance against light based anti-infective agents?
|
Marasini, Sanjay
|
|
|
79-80 |
C |
p.
|
article
|
| 274 |
Carbohydrate-based nanocarriers and their application to target macrophages and deliver antimicrobial agents
|
Mosaiab, Tamim
|
|
|
79-80 |
C |
p. 94-129
|
article
|
| 275 |
Carbon dots as multi-modal contrast agents: opportunities and open challenges for in vivo bioimaging
|
Sturabotti, Elisa
|
|
|
79-80 |
C |
p.
|
article
|
| 276 |
Carbon dots in drug delivery and therapeutic applications
|
Singh, Hemant
|
|
|
79-80 |
C |
p.
|
article
|
| 277 |
Cardiac fibrosis – A short review of causes and therapeutic strategies
|
Hinderer, Svenja
|
|
2019
|
79-80 |
C |
p. 77-82
|
article
|
| 278 |
Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies
|
Liu, Mengrui
|
|
|
79-80 |
C |
p. 504-519
|
article
|
| 279 |
Cardiac macrotissues-on-a-plate models for phenotypic drug screens
|
Meyer, Tim
|
|
2019
|
79-80 |
C |
p. 93-100
|
article
|
| 280 |
Cardiovascular drug delivery with ultrasound and microbubbles
|
Unger, Evan
|
|
2014
|
79-80 |
C |
p. 110-126
17 p.
|
article
|
| 281 |
Careers in nanomedicine and drug delivery
|
Nance, Elizabeth
|
|
|
79-80 |
C |
p. 180-189
|
article
|
| 282 |
Carrier interactions with the biological barriers of the lung: Advanced in vitro models and challenges for pulmonary drug delivery
|
de Souza Carvalho, Cristiane
|
|
2014
|
79-80 |
C |
p. 129-140
12 p.
|
article
|
| 283 |
CAR T-cell bioengineering: Single variable domain of heavy chain antibody targeted CARs
|
Rahbarizadeh, F.
|
|
2019
|
79-80 |
C |
p. 41-46
|
article
|
| 284 |
Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases
|
Dheer, Divya
|
|
|
79-80 |
C |
p. 130-151
|
article
|
| 285 |
C. elegans in high-throughput drug discovery
|
O'Reilly, Linda P.
|
|
2014
|
79-80 |
C |
p. 247-253
7 p.
|
article
|
| 286 |
Cell and biomaterial delivery strategies to induce immune tolerance
|
Scotland, Brianna L.
|
|
|
79-80 |
C |
p.
|
article
|
| 287 |
Cell and tissue engineering in lymph nodes for cancer immunotherapy
|
Najibi, Alexander J.
|
|
|
79-80 |
C |
p. 42-62
|
article
|
| 288 |
Cell based advanced therapeutic medicinal products for bone repair: Keep it simple?
|
Leijten, J.
|
|
2015
|
79-80 |
C |
p. 30-44
15 p.
|
article
|
| 289 |
Cell-based drug delivery systems and their in vivo fate
|
Yang, Liuxin
|
|
|
79-80 |
C |
p.
|
article
|
| 290 |
Cell-based drug testing; this world is not flat
|
Grainger, David W.
|
|
2014
|
79-80 |
C |
p. vii-xi
nvt p.
|
article
|
| 291 |
Cell-based relay delivery strategy in biomedical applications
|
Chen, Yu
|
|
|
79-80 |
C |
p.
|
article
|
| 292 |
Cell encapsulation: Overcoming barriers in cell transplantation in diabetes and beyond
|
Farina, Marco
|
|
2019
|
79-80 |
C |
p. 92-115
|
article
|
| 293 |
Cell encapsulation: ready for the next step
|
de Vos, Paul
|
|
2014
|
79-80 |
C |
p. 1-2
2 p.
|
article
|
| 294 |
Cell-mediated enzyme prodrug cancer therapies
|
Mooney, Rachael
|
|
2017
|
79-80 |
C |
p. 35-51
|
article
|
| 295 |
Cell membrane-coated nanoparticles for targeting carcinogenic bacteria
|
Sun, Lei
|
|
|
79-80 |
C |
p.
|
article
|
| 296 |
Cell-penetrating peptides in protein mimicry and cancer therapeutics
|
Zorko, Matjaž
|
|
|
79-80 |
C |
p.
|
article
|
| 297 |
Cell permeability beyond the rule of 5
|
Matsson, Pär
|
|
2016
|
79-80 |
C |
p. 42-61
20 p.
|
article
|
| 298 |
Cells and secretome – towards endogenous cell re-activation for cartilage repair
|
Stoddart, Martin J.
|
|
2015
|
79-80 |
C |
p. 135-145
11 p.
|
article
|
| 299 |
Cells as advanced therapeutics: State-of-the-art, challenges, and opportunities in large scale biomanufacturing of high-quality cells for adoptive immunotherapies
|
Dwarshuis, Nate J.
|
|
2017
|
79-80 |
C |
p. 222-239
|
article
|
| 300 |
Cell therapy, 3D culture systems and tissue engineering for cardiac regeneration
|
Emmert, Maximilian Y.
|
|
2014
|
79-80 |
C |
p. 254-269
16 p.
|
article
|
| 301 |
Cellular and molecular imaging of CAR-T cell-based immunotherapy
|
Liu, Longwei
|
|
|
79-80 |
C |
p.
|
article
|
| 302 |
Cellular and subcellular interactions of graphene-based materials with cancerous and non-cancerous cells
|
Rahimi, Shadi
|
|
|
79-80 |
C |
p.
|
article
|
| 303 |
Cellular kinetics: A clinical and computational review of CAR-T cell pharmacology
|
Qi, Timothy
|
|
|
79-80 |
C |
p.
|
article
|
| 304 |
Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis
|
Lin, Chien-Yu
|
|
|
79-80 |
C |
p. 127-139
|
article
|
| 305 |
Cellular transformers for targeted therapy
|
Chen, Chen
|
|
|
79-80 |
C |
p.
|
article
|
| 306 |
Cellular uptake and intracellular trafficking of oligonucleotides
|
Juliano, R.L.
|
|
2015
|
79-80 |
C |
p. 35-45
11 p.
|
article
|
| 307 |
Challenges and innovations of delivering medicines to older adults
|
Gnjidic, Danijela
|
|
2018
|
79-80 |
C |
p. 97-105
|
article
|
| 308 |
Challenges and innovations of drug delivery in older age
|
Khan, Muhammad Suleman
|
|
2018
|
79-80 |
C |
p. 3-38
|
article
|
| 309 |
Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy
|
Cruz-Teran, Carlos
|
|
|
79-80 |
C |
p. 100-117
|
article
|
| 310 |
Challenges and opportunities for precision medicine in neurodevelopmental disorders
|
Chen, George T.
|
|
|
79-80 |
C |
p.
|
article
|
| 311 |
Challenges and progress related to gene editing in rare skin diseases
|
Piñón Hofbauer, Josefina
|
|
|
79-80 |
C |
p.
|
article
|
| 312 |
Challenges and solutions in polymer drug delivery for bacterial biofilm treatment: A tissue-by-tissue account
|
Kasza, Karolina
|
|
|
79-80 |
C |
p.
|
article
|
| 313 |
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
|
Hare, Jennifer I.
|
|
2017
|
79-80 |
C |
p. 25-38
14 p.
|
article
|
| 314 |
Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses
|
Forbes, Ben
|
|
2014
|
79-80 |
C |
p. 15-33
19 p.
|
article
|
| 315 |
Challenges in oral drug delivery of antiretrovirals and the innovative strategies to overcome them
|
Sosnik, Alejandro
|
|
|
79-80 |
C |
p. 105-120
|
article
|
| 316 |
Challenges in the clinical assessment of novel tuberculosis drugs
|
Dooley, Kelly E.
|
|
2016
|
79-80 |
C |
p. 116-122
7 p.
|
article
|
| 317 |
Challenges of fused deposition modeling 3D printing in pharmaceutical applications: Where are we now?
|
Parulski, Chloé
|
|
|
79-80 |
C |
p.
|
article
|
| 318 |
Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers
|
Yang, Juanjuan
|
|
|
79-80 |
C |
p.
|
article
|
| 319 |
Chaotic (bio)printing in the context of drug delivery systems
|
Alvarez, Mario Moisés
|
|
|
79-80 |
C |
p.
|
article
|
| 320 |
Characterization and impact of peptide physicochemical properties on oral and subcutaneous delivery
|
Klepach, Alisa
|
|
|
79-80 |
C |
p.
|
article
|
| 321 |
Characterization of dry powder inhaler performance through experimental methods
|
Ruzycki, Conor A.
|
|
|
79-80 |
C |
p.
|
article
|
| 322 |
Chemical and structural modifications of RNAi therapeutics
|
Ku, Sook Hee
|
|
2016
|
79-80 |
C |
p. 16-28
13 p.
|
article
|
| 323 |
Chemical degradation of proteins in the solid state with a focus on photochemical reactions
|
Mozziconacci, Olivier
|
|
2015
|
79-80 |
C |
p. 2-13
12 p.
|
article
|
| 324 |
Chemical modification of drug molecules as strategy to reduce interactions with mucus
|
Araújo, Francisca
|
|
2018
|
79-80 |
C |
p. 98-106
|
article
|
| 325 |
Chemical (neo)glycosylation of biological drugs
|
Walther, Raoul
|
|
|
79-80 |
C |
p. 62-76
|
article
|
| 326 |
Chronopharmacology of glucocorticoids
|
Scherholz, Megerle L.
|
|
|
79-80 |
C |
p. 245-261
|
article
|
| 327 |
Circadian attributes of neurological and psychiatric disorders as basis for their medication chronotherapy
|
Khoshnevis, Sepideh
|
|
|
79-80 |
C |
p.
|
article
|
| 328 |
Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy
|
Cheng, Guofeng
|
|
2015
|
79-80 |
C |
p. 75-93
19 p.
|
article
|
| 329 |
Clinical application of microencapsulated islets: Actual prospectives on progress and challenges
|
Calafiore, Riccardo
|
|
2014
|
79-80 |
C |
p. 84-92
9 p.
|
article
|
| 330 |
Clinical applications of pulmonary delivery of antibiotics
|
Flume, Patrick A.
|
|
2015
|
79-80 |
C |
p. 1-6
6 p.
|
article
|
| 331 |
Clinical applications of the CellSearch platform in cancer patients
|
Riethdorf, Sabine
|
|
|
79-80 |
C |
p. 102-121
|
article
|
| 332 |
Clinical challenges in HIV/AIDS: Hints for advancing prevention and patient management strategies
|
Sued, Omar
|
|
|
79-80 |
C |
p. 5-19
|
article
|
| 333 |
Clinical delivery of circular RNA: Lessons learned from RNA drug development
|
Loan Young, Tiana
|
|
|
79-80 |
C |
p.
|
article
|
| 334 |
Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer
|
Rachagani, Satyanarayana
|
|
2015
|
79-80 |
C |
p. 16-33
18 p.
|
article
|
| 335 |
Clinical indications for, and the future of, circulating tumor cells
|
Moon, Dominic H.
|
|
|
79-80 |
C |
p. 143-150
|
article
|
| 336 |
Clinically established biodegradable long acting injectables: An industry perspective
|
Nkanga, Christian Isalomboto
|
|
|
79-80 |
C |
p. 19-46
|
article
|
| 337 |
Clinically-relevant and predictive cancer models for nanomedicine evaluation
|
Satchi-Fainaro, Ronit
|
|
|
79-80 |
C |
p.
|
article
|
| 338 |
Clinical perspective on topical vaccination strategies
|
G. Popova, Petya
|
|
|
79-80 |
C |
p.
|
article
|
| 339 |
Clinical pharmacology strategies to accelerate the development of polatuzumab vedotin and summary of key findings
|
Liao, Michael Z.
|
|
|
79-80 |
C |
p.
|
article
|
| 340 |
Clinical translational barriers against nanoparticle-based imaging agents
|
Jin, Rongrong
|
|
|
79-80 |
C |
p.
|
article
|
| 341 |
Clinical translation of advanced colonic drug delivery technologies
|
Awad, Atheer
|
|
|
79-80 |
C |
p.
|
article
|
| 342 |
Clinical translation of immunomodulatory therapeutics
|
Nash, Amanda
|
|
|
79-80 |
C |
p.
|
article
|
| 343 |
Clinical translation of nanomedicines: Challenges, opportunities, and keys
|
Younis, Mahmoud A.
|
|
|
79-80 |
C |
p.
|
article
|
| 344 |
Clinical translation of stem cell based interventions for spinal cord injury — Are we there yet?
|
Chhabra, Harvinder S.
|
|
2017
|
79-80 |
C |
p. 41-49
|
article
|
| 345 |
Clinical utility of non-EpCAM based circulating tumor cell assays
|
Austin, R. Garland
|
|
|
79-80 |
C |
p. 132-142
|
article
|
| 346 |
Co association of mucus modulating agents and nanoparticles for mucosal drug delivery
|
Nordgård, Catherine Taylor
|
|
2018
|
79-80 |
C |
p. 175-183
|
article
|
| 347 |
Coaxing stem cells for skeletal muscle repair
|
McCullagh, Karl J.A.
|
|
2015
|
79-80 |
C |
p. 198-207
10 p.
|
article
|
| 348 |
Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5
|
Kuminek, Gislaine
|
|
2016
|
79-80 |
C |
p. 143-166
24 p.
|
article
|
| 349 |
Co-delivery of chemotherapeutics and proteins for synergistic therapy
|
He, Chaoliang
|
|
2016
|
79-80 |
C |
p. 64-76
13 p.
|
article
|
| 350 |
Co-delivery of drugs and plasmid DNA for cancer therapy
|
Teo, Pei Yun
|
|
2016
|
79-80 |
C |
p. 41-63
23 p.
|
article
|
| 351 |
Coiled coil-based therapeutics and drug delivery systems
|
Utterström, Johanna
|
|
|
79-80 |
C |
p. 26-43
|
article
|
| 352 |
Collagen interactions: Drug design and delivery
|
An, Bo
|
|
2016
|
79-80 |
C |
p. 69-84
16 p.
|
article
|
| 353 |
Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs
|
Vithani, Kapilkumar
|
|
2019
|
79-80 |
C |
p. 16-34
|
article
|
| 354 |
Colonizing microbiota is associated with clinical outcomes in diabetic wound healing
|
Wang, Gaofeng
|
|
|
79-80 |
C |
p.
|
article
|
| 355 |
Combatting infectious diseases; nanotechnology as a platform for rational vaccine design
|
van Riet, Elly
|
|
2014
|
79-80 |
C |
p. 28-34
7 p.
|
article
|
| 356 |
Combination antitumor therapy with targeted dual-nanomedicines
|
Dai, Wenbing
|
|
2017
|
79-80 |
C |
p. 23-45
23 p.
|
article
|
| 357 |
Combination of microRNA therapeutics with small-molecule anticancer drugs: Mechanism of action and co-delivery nanocarriers
|
Dai, Xin
|
|
2015
|
79-80 |
C |
p. 184-197
14 p.
|
article
|
| 358 |
Combinatorial drug delivery approaches for immunomodulation
|
Stewart, Joshua M.
|
|
2017
|
79-80 |
C |
p. 161-174
|
article
|
| 359 |
Combinatorial immunotherapy and nanoparticle mediated hyperthermia
|
Moy, Austin J.
|
|
2017
|
79-80 |
C |
p. 175-183
|
article
|
| 360 |
Combined use of nanocarriers and physical methods for percutaneous penetration enhancement
|
Dragicevic, Nina
|
|
|
79-80 |
C |
p. 58-84
|
article
|
| 361 |
Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity
|
Northrup, Laura
|
|
2016
|
79-80 |
C |
p. 86-98
13 p.
|
article
|
| 362 |
“Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy
|
Kemp, Jessica A.
|
|
2016
|
79-80 |
C |
p. 3-18
16 p.
|
article
|
| 363 |
Comment on: Inhaled antimicrobial therapy—Barriers to effective treatment, by J.Weers, Adv. Drug Deliv. Rev. (2014), http://dx.doi.org/ 10.1016/j.addr.2014.08.013
|
de Boer, A.H.
|
|
2015
|
79-80 |
C |
p. e1-e2
nvt p.
|
article
|
| 364 |
Comment on: Inhaled antimicrobial therapy—Barriers to effective treatment, by J. Weers, Inhaled antimicrobial therapy — Barriers to effective treatment, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013
|
Cipolla, David
|
|
2015
|
79-80 |
C |
p. e6-e7
nvt p.
|
article
|
| 365 |
Complement activation by drug carriers and particulate pharmaceuticals: Principles, challenges and opportunities
|
Moghimi, S. Moein
|
|
|
79-80 |
C |
p. 83-95
|
article
|
| 366 |
Computational investigations of hERG channel blockers: New insights and current predictive models
|
Villoutreix, Bruno O.
|
|
2015
|
79-80 |
C |
p. 72-82
11 p.
|
article
|
| 367 |
Computational modelling of drug delivery to solid tumour: Understanding the interplay between chemotherapeutics and biological system for optimised delivery systems
|
Zhan, Wenbo
|
|
2018
|
79-80 |
C |
p. 81-103
|
article
|
| 368 |
Computational prediction of formulation strategies for beyond-rule-of-5 compounds
|
Bergström, Christel A.S.
|
|
2016
|
79-80 |
C |
p. 6-21
16 p.
|
article
|
| 369 |
Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine
|
Donahue, Nathan D.
|
|
|
79-80 |
C |
p. 68-96
|
article
|
| 370 |
Confronting antifungal resistance, tolerance, and persistence: Advances in drug target discovery and delivery systems
|
Chen, Lei
|
|
|
79-80 |
C |
p.
|
article
|
| 371 |
Conjugated polymer nano-systems for hyperthermia, imaging and drug delivery
|
Sarkar, Santu
|
|
|
79-80 |
C |
p. 40-64
|
article
|
| 372 |
Connected healthcare: Improving patient care using digital health technologies
|
Awad, Atheer
|
|
|
79-80 |
C |
p.
|
article
|
| 373 |
Consideration of the cellular microenvironment: Physiologically relevant co-culture systems in drug discovery
|
L. Berg, Ellen
|
|
2014
|
79-80 |
C |
p. 190-204
15 p.
|
article
|
| 374 |
Considerations for personalized neoantigen vaccination in Malignant glioma
|
Dunn, Gavin P.
|
|
|
79-80 |
C |
p.
|
article
|
| 375 |
Contrast agents for preclinical targeted X-ray imaging
|
Li, Xiang
|
|
2014
|
79-80 |
C |
p. 116-133
18 p.
|
article
|
| 376 |
Contribution of bioinformatics prediction in microRNA-based cancer therapeutics
|
Banwait, Jasjit K.
|
|
2015
|
79-80 |
C |
p. 94-103
10 p.
|
article
|
| 377 |
Controlled release of drugs in electrosprayed nanoparticles for bone tissue engineering
|
Jayaraman, Praveena
|
|
2015
|
79-80 |
C |
p. 77-95
19 p.
|
article
|
| 378 |
Controlled release technology for anti-angiogenesis treatment of posterior eye diseases: Current status and challenges
|
Lau, Chi Ming Laurence
|
|
2018
|
79-80 |
C |
p. 145-161
|
article
|
| 379 |
Controlling drug release with additive manufacturing-based solutions
|
Patel, Shriya K.
|
|
|
79-80 |
C |
p. 369-386
|
article
|
| 380 |
Controlling the function of genes and biologically active nucleic acids
|
Nishikawa, Makiya
|
|
|
79-80 |
C |
p. 1
|
article
|
| 381 |
Controlling timing and location in vaccines
|
Irvine, Darrell J.
|
|
|
79-80 |
C |
p. 91-115
|
article
|
| 382 |
Convection-enhanced delivery for brain malignancies: Technical parameters, formulation strategies and clinical perspectives
|
Parvar, Sara Jamshidi
|
|
|
79-80 |
C |
p.
|
article
|
| 383 |
Corneal fibrosis: From in vitro models to current and upcoming drug and gene medicines
|
Trujillo Cubillo, Laura
|
|
|
79-80 |
C |
p.
|
article
|
| 384 |
Correlation and clinical relevance of animal models for inhaled pharmaceuticals and biopharmaceuticals
|
Sécher, T.
|
|
|
79-80 |
C |
p. 148-169
|
article
|
| 385 |
Corrigendum to “Advanced theragnostics for the central nervous system (CNS) and neurological disorders using functional inorganic nanomaterials” [Adv. Drug Delivery Rev. 192 (2023) 114636]
|
Conklin, Brandon
|
|
|
79-80 |
C |
p.
|
article
|
| 386 |
Corrigendum to ‘Cell-penetrating peptides in protein mimicry and cancer therapeutics’ [Advanced Drug Delivery Reviews, 180 (2022), 114044]
|
Zorko, M.
|
|
|
79-80 |
C |
p.
|
article
|
| 387 |
Corrigendum to ‘Current state and challenges in developing oral vaccines’ [Adv. Drug Deliv. Rev. 114 (2017) 116-131]
|
Vela Ramirez, Julia E.
|
|
2019
|
79-80 |
C |
p. 158
|
article
|
| 388 |
Corrigendum to “Editorial: Advanced strategies to bridge the gap between inflammation and tissue regeneration” [Adv. Drug Deliv. Rev. 209 (2024) 115328]
|
Rodrigues, Márcia T.
|
|
|
79-80 |
C |
p.
|
article
|
| 389 |
Corrigendum to “Light sheet fluorescence microscopy for monitoring drug delivery: unlocking the developmental phases of embryos” [Adv Drug Del. Rev. 218 (2025) 115520]
|
Raju, Gagan
|
|
|
79-80 |
C |
p.
|
article
|
| 390 |
Corrigendum to “Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers” [Adv. Drug Delivery Rev. 203 (2023) 115136]
|
Yaghmur, Anan
|
|
|
79-80 |
C |
p.
|
article
|
| 391 |
Corrigendum to “Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic” [Adv. Drug Delivery Rev. 179 (2021) 114000]
|
Jain, Samagra
|
|
|
79-80 |
C |
p.
|
article
|
| 392 |
Corrigendum to “Overcoming ocular drug delivery barriers through the use of physical forces” [Advanced Drug Delivery Reviews 126 (2018) 96–112]
|
Huang, Di
|
|
2019
|
79-80 |
C |
p. 157
|
article
|
| 393 |
Corrigendum to ‘Tumor-targeting peptides from combinatorial libraries’ [Adv Drug Deliv Rev.110–111 (2017) 13–37]
|
Liu, Ruiwu
|
|
|
79-80 |
C |
p. 152
|
article
|
| 394 |
Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performance
|
Bandari, Suresh
|
|
|
79-80 |
C |
p. 52-63
|
article
|
| 395 |
Covalent nano delivery systems for selective imaging and treatment of brain tumors
|
Ljubimova, Julia Y.
|
|
2017
|
79-80 |
C |
p. 177-200
24 p.
|
article
|
| 396 |
COVID-19: An unprecedented challenge and an opportunity for change
|
Kwon, Young Jik
|
|
|
79-80 |
C |
p. 48-49
|
article
|
| 397 |
COVID-19 vaccines: The status and perspectives in delivery points of view
|
Chung, Jee Young
|
|
|
79-80 |
C |
p. 1-25
|
article
|
| 398 |
Cowpea mosaic virus nanoparticles for cancer imaging and therapy
|
Beatty, Perrin H.
|
|
2019
|
79-80 |
C |
p. 130-144
|
article
|
| 399 |
CRISPR/Cas bioimaging: From whole body biodistribution to single-cell dynamics
|
Kolesova, Ekaterina
|
|
|
79-80 |
C |
p.
|
article
|
| 400 |
CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells
|
Bloomer, Hanan
|
|
|
79-80 |
C |
p.
|
article
|
| 401 |
CRISPR/Cas systems to overcome challenges in developing the next generation of T cells for cancer therapy
|
Huang, Dennis
|
|
|
79-80 |
C |
p. 17-35
|
article
|
| 402 |
Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments
|
Astashkina, Anna
|
|
2014
|
79-80 |
C |
p. 1-18
18 p.
|
article
|
| 403 |
Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation
|
Afonin, Kirill A.
|
|
|
79-80 |
C |
p.
|
article
|
| 404 |
Crossing borders in Alzheimer’s disease: A T cell’s perspective
|
van Olst, L.
|
|
|
79-80 |
C |
p.
|
article
|
| 405 |
Crystalline mesophases: Structure, mobility, and pharmaceutical properties
|
Shalaev, Evgenyi
|
|
2016
|
79-80 |
C |
p. 194-211
18 p.
|
article
|
| 406 |
Current advances in self-assembled nanogel delivery systems for immunotherapy
|
Tahara, Yoshiro
|
|
2015
|
79-80 |
C |
p. 65-76
12 p.
|
article
|
| 407 |
Current and Emerging Inhaled Therapies of Repositioned Drugs
|
Cipolla, David
|
|
2018
|
79-80 |
C |
p. 1-4
|
article
|
| 408 |
Current and forthcoming approaches for systemic detoxification
|
Zhang, Liangfang
|
|
2015
|
79-80 |
C |
p. 1-2
2 p.
|
article
|
| 409 |
Current and future directions of drug delivery for the treatment of mental illnesses
|
Brewster, Parker R.
|
|
|
79-80 |
C |
p.
|
article
|
| 410 |
Current and future technological advances in transdermal gene delivery
|
Chen, Xianfeng
|
|
|
79-80 |
C |
p. 85-105
|
article
|
| 411 |
Current and prospective computational approaches and challenges for developing COVID-19 vaccines
|
Hwang, Woochang
|
|
|
79-80 |
C |
p. 249-274
|
article
|
| 412 |
Current and upcoming therapies to modulate skin scarring and fibrosis
|
Coentro, João Q.
|
|
2019
|
79-80 |
C |
p. 37-59
|
article
|
| 413 |
Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network
|
Vinarov, Zahari
|
|
|
79-80 |
C |
p. 289-331
|
article
|
| 414 |
Current developments and applications of microfluidic technology toward clinical translation of nanomedicines
|
Liu, Dongfei
|
|
2018
|
79-80 |
C |
p. 54-83
|
article
|
| 415 |
Current issues in optical monitoring of drug delivery via hair follicles
|
Svenskaya, Yulia I.
|
|
|
79-80 |
C |
p.
|
article
|
| 416 |
Current preclinical small interfering RNA (siRNA)-based conjugate systems for RNA therapeutics
|
Lee, Soo Hyeon
|
|
2016
|
79-80 |
C |
p. 78-92
15 p.
|
article
|
| 417 |
Current progress and limitations of AAV mediated delivery of protein therapeutic genes and the importance of developing quantitative pharmacokinetic/pharmacodynamic (PK/PD) models
|
Chowdhury, Ekram Ahmed
|
|
|
79-80 |
C |
p. 214-237
|
article
|
| 418 |
Current state and challenges in developing oral vaccines
|
Vela Ramirez, Julia E.
|
|
2017
|
79-80 |
C |
p. 116-131
|
article
|
| 419 |
Current state of in vivo panning technologies: Designing specificity and affinity into the future of drug targeting
|
Gustafson, Heather H.
|
|
2018
|
79-80 |
C |
p. 39-49
|
article
|
| 420 |
Current status and challenges of model-informed drug discovery and development in China
|
Wang, Yuzhu
|
|
|
79-80 |
C |
p.
|
article
|
| 421 |
Current strategies and opportunities to manufacture cells for modeling human lungs
|
Varma, Ratna
|
|
|
79-80 |
C |
p. 90-109
|
article
|
| 422 |
Current treatment options and novel nanotechnology-driven enzyme replacement strategies for lysosomal storage disorders
|
Del Grosso, Ambra
|
|
|
79-80 |
C |
p.
|
article
|
| 423 |
Current trends in biologics delivery to restore intervertebral disc anabolism
|
Fontana, Gianluca
|
|
2015
|
79-80 |
C |
p. 146-158
13 p.
|
article
|
| 424 |
Current trends in delivery of non-viral nucleic acid-based therapeutics for improved efficacy
|
Avci-Adali, Meltem
|
|
|
79-80 |
C |
p.
|
article
|
| 425 |
Current understandings and clinical translation of nanomedicines for breast cancer therapy
|
Jiang, Yike
|
|
|
79-80 |
C |
p.
|
article
|
| 426 |
Cyclodextrins applied to the treatment of lysosomal storage disorders
|
Ishitsuka, Yoichi
|
|
|
79-80 |
C |
p.
|
article
|
| 427 |
Cytokine conjugates to elastin-like polypeptides
|
Gong, Like
|
|
|
79-80 |
C |
p.
|
article
|
| 428 |
Cytoskeleton-modulating nanomaterials and their therapeutic potentials
|
Park, Jinwon
|
|
|
79-80 |
C |
p.
|
article
|
| 429 |
D-amino acid-containing supramolecular nanofibers for potential cancer therapeutics
|
Wang, Huaimin
|
|
2017
|
79-80 |
C |
p. 102-111
10 p.
|
article
|
| 430 |
Dancing with reactive oxygen species generation and elimination in nanotheranostics for disease treatment
|
Zhou, Zijian
|
|
|
79-80 |
C |
p. 73-90
|
article
|
| 431 |
3D — A new dimension of in vitro research
|
Hartung, Thomas
|
|
2014
|
79-80 |
C |
p. vi-
1 p.
|
article
|
| 432 |
Dawn of lipid nanoparticles in lymph node targeting: Potential in cancer immunotherapy
|
Nakamura, Takashi
|
|
|
79-80 |
C |
p. 78-88
|
article
|
| 433 |
3D-Bioprinting and Micro-/Nano-Technology: Emerging Technologies in Biomedical Sciences
|
Wang, Chi-Hwa
|
|
2018
|
79-80 |
C |
p. 1-2
|
article
|
| 434 |
3D bioprinting for cardiovascular regeneration and pharmacology
|
Cui, Haitao
|
|
2018
|
79-80 |
C |
p. 252-269
|
article
|
| 435 |
3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling
|
Ma, Xuanyi
|
|
2018
|
79-80 |
C |
p. 235-251
|
article
|
| 436 |
3D bioprinting of skin tissue: From pre-processing to final product evaluation
|
Yan, Wei-Cheng
|
|
2018
|
79-80 |
C |
p. 270-295
|
article
|
| 437 |
3D bioprinting of tissues and organs for regenerative medicine
|
Vijayavenkataraman, Sanjairaj
|
|
2018
|
79-80 |
C |
p. 296-332
|
article
|
| 438 |
3D cell culture systems modeling tumor growth determinants in cancer target discovery
|
Thoma, Claudio R.
|
|
2014
|
79-80 |
C |
p. 29-41
13 p.
|
article
|
| 439 |
Decellularized myocardial matrix hydrogels: In basic research and preclinical studies
|
Wang, Raymond M.
|
|
2016
|
79-80 |
C |
p. 77-82
6 p.
|
article
|
| 440 |
Deciphering albumin-directed drug delivery by imaging
|
Hu, Huiyu
|
|
|
79-80 |
C |
p.
|
article
|
| 441 |
Decision support systems for personalized and participative radiation oncology
|
Lambin, Philippe
|
|
2017
|
79-80 |
C |
p. 131-153
23 p.
|
article
|
| 442 |
Decorated bacteria and the application in drug delivery
|
Wu, Feng
|
|
|
79-80 |
C |
p.
|
article
|
| 443 |
Decorin as a multivalent therapeutic agent against cancer
|
Neill, Thomas
|
|
2016
|
79-80 |
C |
p. 174-185
12 p.
|
article
|
| 444 |
DectiSomes: C-type lectin receptor-targeted liposomes as pan-antifungal drugs
|
Meagher, Richard B.
|
|
|
79-80 |
C |
p.
|
article
|
| 445 |
Deepening the understanding of the in vivo and cellular fate of nanocarriers
|
Wu, Wei
|
|
|
79-80 |
C |
p.
|
article
|
| 446 |
Defensins: The natural peptide antibiotic
|
Gao, Xihui
|
|
|
79-80 |
C |
p.
|
article
|
| 447 |
Delivering drugs to the lungs: The history of repurposing in the treatment of respiratory diseases
|
Newman, Stephen P.
|
|
2018
|
79-80 |
C |
p. 5-18
|
article
|
| 448 |
Delivering macrolide antibiotics to heal a broken heart – And other inflammatory conditions
|
Venditto, Vincent J.
|
|
|
79-80 |
C |
p.
|
article
|
| 449 |
Delivering more for less: nanosized, minimal-carrier and pharmacoactive drug delivery systems
|
Etter, Emma L.
|
|
|
79-80 |
C |
p.
|
article
|
| 450 |
Delivering on the promise of recombinant silk-inspired proteins for drug delivery
|
Gonzalez-Obeso, Constancio
|
|
|
79-80 |
C |
p.
|
article
|
| 451 |
Delivering safer immunotherapies for cancer
|
Milling, Lauren
|
|
2017
|
79-80 |
C |
p. 79-101
|
article
|
| 452 |
Delivery and kinetics of immersion optical clearing agents in tissues: Optical imaging from ex vivo to in vivo
|
Yu, Tingting
|
|
|
79-80 |
C |
p.
|
article
|
| 453 |
Delivery of antibiotics with polymeric particles
|
Xiong, Meng-Hua
|
|
2014
|
79-80 |
C |
p. 63-76
14 p.
|
article
|
| 454 |
Delivery of biomacromolecules for therapeutic genome editing
|
Ping, Yuan
|
|
|
79-80 |
C |
p. 1-2
|
article
|
| 455 |
Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities
|
Au, Jessie L.-S.
|
|
2016
|
79-80 |
C |
p. 280-301
22 p.
|
article
|
| 456 |
Delivery of cellular factors to regulate bone healing
|
Haumer, Alexander
|
|
|
79-80 |
C |
p. 285-294
|
article
|
| 457 |
Delivery of CRISPR-Cas9 system for screening and editing RNA binding proteins in cancer
|
Yan, Jingyue
|
|
|
79-80 |
C |
p.
|
article
|
| 458 |
Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy
|
Song, Xiangrong
|
|
|
79-80 |
C |
p. 158-180
|
article
|
| 459 |
Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles
|
Luther, David C.
|
|
|
79-80 |
C |
p. 188-213
|
article
|
| 460 |
Delivery of genome-editing biomacromolecules for treatment of lung genetic disorders
|
Wan, Tao
|
|
|
79-80 |
C |
p. 196-216
|
article
|
| 461 |
Delivery of inhalation drugs to children for asthma and other respiratory diseases
|
Kwok, Philip Chi Lip
|
|
2014
|
79-80 |
C |
p. 83-88
6 p.
|
article
|
| 462 |
Delivery of miRNAs to the adipose organ for metabolic health
|
Kornmueller, Karin
|
|
|
79-80 |
C |
p.
|
article
|
| 463 |
Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications
|
Masarwy, Razan
|
|
|
79-80 |
C |
p.
|
article
|
| 464 |
Delivery of oligonucleotides with lipid nanoparticles
|
Wang, Yuhua
|
|
2015
|
79-80 |
C |
p. 68-80
13 p.
|
article
|
| 465 |
Delivery of STING agonists for adjuvanting subunit vaccines
|
Van Herck, Simon
|
|
|
79-80 |
C |
p.
|
article
|
| 466 |
Delivery of synthetic mRNAs for tissue regeneration
|
Steinle, Heidrun
|
|
|
79-80 |
C |
p.
|
article
|
| 467 |
Delivery of therapeutic oligonucleotides with cell penetrating peptides
|
Boisguérin, Prisca
|
|
2015
|
79-80 |
C |
p. 52-67
16 p.
|
article
|
| 468 |
Delivery strategies and potential targets for siRNA in major cancer types
|
Lee, So Jin
|
|
2016
|
79-80 |
C |
p. 2-15
14 p.
|
article
|
| 469 |
Delivery strategies for sustained drug release in the lungs
|
Loira-Pastoriza, Cristina
|
|
2014
|
79-80 |
C |
p. 81-91
11 p.
|
article
|
| 470 |
Delivery strategies to enhance oral vaccination against enteric infections
|
Davitt, Christopher J.H.
|
|
2015
|
79-80 |
C |
p. 52-69
18 p.
|
article
|
| 471 |
Delivery systems for the treatment of degenerated intervertebral discs
|
Blanquer, S.B.G.
|
|
2015
|
79-80 |
C |
p. 172-187
16 p.
|
article
|
| 472 |
Delivery systems of current biologicals for the treatment of chronic cutaneous wounds and severe burns
|
Xue, Meilang
|
|
|
79-80 |
C |
p. 219-241
|
article
|
| 473 |
Delivery technologies for in utero gene therapy
|
Palanki, Rohan
|
|
|
79-80 |
C |
p. 51-62
|
article
|
| 474 |
Delivery technologies for therapeutic targeting of fibronectin in autoimmunity and fibrosis applications
|
Bonadio, Jacob D.
|
|
|
79-80 |
C |
p.
|
article
|
| 475 |
Demystifying phytoconstituent-derived nanomedicines in their immunoregulatory and therapeutic roles in inflammatory diseases
|
Chen, Fengqian
|
|
|
79-80 |
C |
p.
|
article
|
| 476 |
Dennis Sandell (1960–2020)
|
Asking, Lars
|
|
|
79-80 |
C |
p.
|
article
|
| 477 |
Design control considerations for biologic-device combination products
|
Anderson, Dave
|
|
2017
|
79-80 |
C |
p. 101-105
5 p.
|
article
|
| 478 |
Design, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles
|
Rijcken, Cristianne J.F.
|
|
|
79-80 |
C |
p.
|
article
|
| 479 |
Designer bacteria as intratumoural enzyme biofactories
|
Lehouritis, Panos
|
|
2017
|
79-80 |
C |
p. 8-23
|
article
|
| 480 |
Designer outer membrane vesicles as immunomodulatory systems – Reprogramming bacteria for vaccine delivery
|
Gnopo, Yehou M.D.
|
|
2017
|
79-80 |
C |
p. 132-142
|
article
|
| 481 |
Designing electrospun fiber platforms for efficient delivery of genetic material and genome editing tools
|
Puhl, Devan L.
|
|
|
79-80 |
C |
p.
|
article
|
| 482 |
Designing live bacterial therapeutics for cancer
|
Lee, Jaehyun
|
|
|
79-80 |
C |
p.
|
article
|
| 483 |
Designing metal-contained enzyme mimics for prodrug activation
|
Du, Baoji
|
|
2017
|
79-80 |
C |
p. 78-93
|
article
|
| 484 |
Designing peptide nanoparticles for efficient brain delivery
|
Duro-Castano, Aroa
|
|
|
79-80 |
C |
p. 52-77
|
article
|
| 485 |
Design of disintegrable nanoassemblies to release multiple small-sized nanoparticles
|
Zhu, Dingcheng
|
|
|
79-80 |
C |
p.
|
article
|
| 486 |
Design strategies and applications of smart optical probes in the second near-infrared window
|
Chang, Baisong
|
|
|
79-80 |
C |
p.
|
article
|
| 487 |
Design strategies for shape-controlled magnetic iron oxide nanoparticles
|
Roca, Alejandro G.
|
|
2019
|
79-80 |
C |
p. 68-104
|
article
|
| 488 |
Design, synthesis and biological applications of glycopolypeptides
|
Clauss, Zachary S.
|
|
|
79-80 |
C |
p. 152-167
|
article
|
| 489 |
Destruction of tumor vasculature by vascular disrupting agents in overcoming the limitation of EPR effect
|
Liu, Zhilin
|
|
|
79-80 |
C |
p.
|
article
|
| 490 |
Development and aging of the lymphatic vascular system
|
González-Loyola, Alejandra
|
|
|
79-80 |
C |
p. 63-78
|
article
|
| 491 |
Development and delivery of anti-tuberculosis drugs, vaccines and immunotherapeutics
|
Triccas, James A.
|
|
2016
|
79-80 |
C |
p. 1-2
2 p.
|
article
|
| 492 |
Development of a virus-mimicking nanocarrier for drug delivery systems: The bio-nanocapsule
|
Somiya, Masaharu
|
|
2015
|
79-80 |
C |
p. 77-89
13 p.
|
article
|
| 493 |
Development of extracellular vesicle-based medicinal products: A position paper of the group “Extracellular Vesicle translatiOn to clinicaL perspectiVEs – EVOLVE France”
|
Silva, Amanda K.A.
|
|
|
79-80 |
C |
p.
|
article
|
| 494 |
Development of lipid-like materials for RNA delivery based on intracellular environment-responsive membrane destabilization and spontaneous collapse
|
Tanaka, Hiroki
|
|
|
79-80 |
C |
p. 210-226
|
article
|
| 495 |
Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy
|
Mekaru, Harutaka
|
|
2015
|
79-80 |
C |
p. 40-49
10 p.
|
article
|
| 496 |
Development of nucleic acid medicines based on chemical technology
|
Kawamoto, Yusuke
|
|
|
79-80 |
C |
p.
|
article
|
| 497 |
Development of Promitil®, a lipidic prodrug of mitomycin c in PEGylated liposomes: From bench to bedside
|
Gabizon, Alberto
|
|
|
79-80 |
C |
p. 13-26
|
article
|
| 498 |
Developments in extracorporeal therapy for the poisoned patient
|
Patel, Nikunjkumar
|
|
2015
|
79-80 |
C |
p. 3-11
9 p.
|
article
|
| 499 |
Device-assisted transdermal drug delivery
|
Lee, Hyunjae
|
|
|
79-80 |
C |
p. 35-45
|
article
|
| 500 |
Devices for drug delivery in the gastrointestinal tract: A review of systems physically interacting with the mucosa for enhanced delivery
|
Byrne, James
|
|
|
79-80 |
C |
p.
|
article
|
| 501 |
Devices to overcome the buccal mucosal barrier to administer therapeutic peptides
|
Malhotra, Sahil
|
|
|
79-80 |
C |
p.
|
article
|
| 502 |
Device thrombosis and pre-clinical blood flow models for assessing antithrombogenic efficacy of drug-device combinations
|
Sukavaneshvar, Sivaprasad
|
|
2017
|
79-80 |
C |
p. 24-34
11 p.
|
article
|
| 503 |
3D extrusion bioprinting of microbial inks for biomedical applications
|
Burns, Nicolas
|
|
|
79-80 |
C |
p.
|
article
|
| 504 |
Diabetes associated fibrosis and drug delivery
|
Su, Qiaozhu
|
|
|
79-80 |
C |
p.
|
article
|
| 505 |
3D in vitro models of liver fibrosis
|
van Grunsven, Leo A.
|
|
2017
|
79-80 |
C |
p. 133-146
|
article
|
| 506 |
Direct measurement of molecular mobility and crystallisation of amorphous pharmaceuticals using terahertz spectroscopy
|
Sibik, Juraj
|
|
2016
|
79-80 |
C |
p. 147-157
11 p.
|
article
|
| 507 |
Diseases and conditions that impact maternal and fetal health and the potential for nanomedicine therapies
|
Nelson, Katherine M.
|
|
|
79-80 |
C |
p. 425-438
|
article
|
| 508 |
2D materials-based nanomedicine: From discovery to applications
|
Ouyang, Jiang
|
|
|
79-80 |
C |
p.
|
article
|
| 509 |
2D materials for bone therapy
|
Wang, Xiangjiang
|
|
|
79-80 |
C |
p.
|
article
|
| 510 |
DNA and RNA derivatives to optimize distribution and delivery
|
Wickstrom, Eric
|
|
2015
|
79-80 |
C |
p. 25-34
10 p.
|
article
|
| 511 |
DNA-Based nanostructures for tumor microenvironment-responsive drug delivery
|
Li, Siqi
|
|
|
79-80 |
C |
p.
|
article
|
| 512 |
DNA hydrogel-based gene editing and drug delivery systems
|
Mo, Fangli
|
|
|
79-80 |
C |
p. 79-98
|
article
|
| 513 |
Domesticating the foreign body response: Recent advances and applications
|
Veiseh, Omid
|
|
|
79-80 |
C |
p. 148-161
|
article
|
| 514 |
Dosage form modification and oral drug delivery in older people
|
Lau, Esther T.L.
|
|
2018
|
79-80 |
C |
p. 75-84
|
article
|
| 515 |
Dosing extracellular vesicles
|
Gupta, Dhanu
|
|
|
79-80 |
C |
p.
|
article
|
| 516 |
3D printed drug delivery and testing systems — a passing fad or the future?
|
Lim, Seng Han
|
|
2018
|
79-80 |
C |
p. 139-168
|
article
|
| 517 |
3D printed implantable drug delivery devices for women’s health: Formulation challenges and regulatory perspective
|
Al-Litani, Karen
|
|
|
79-80 |
C |
p.
|
article
|
| 518 |
3D printed metamaterials: properties, fabrication, and drug delivery applications
|
Singh, Hemant
|
|
|
79-80 |
C |
p.
|
article
|
| 519 |
3D printing as a transformative tool for microneedle systems: Recent advances, manufacturing considerations and market potential
|
Economidou, Sophia N.
|
|
|
79-80 |
C |
p. 60-69
|
article
|
| 520 |
3D printing-enabled spatial patterning of biomimetic signals for bone tissue engineering
|
Loukelis, Konstantinos
|
|
|
79-80 |
C |
p.
|
article
|
| 521 |
3D printing of drug delivery systems enhanced with micro/nano-technology
|
Zhu, Hui
|
|
|
79-80 |
C |
p.
|
article
|
| 522 |
3D printing of pharmaceutical dosage forms: Recent advances and applications
|
Auel, Tobias
|
|
|
79-80 |
C |
p.
|
article
|
| 523 |
Droplet-based 3D bioprinting for drug delivery and screening
|
Xu, Heqi
|
|
|
79-80 |
C |
p.
|
article
|
| 524 |
Drug and cell delivery for cardiac regeneration
|
Hastings, Conn L.
|
|
2015
|
79-80 |
C |
p. 85-106
22 p.
|
article
|
| 525 |
Drug and cell encapsulation: Alternative delivery options for the treatment of malignant brain tumors
|
Bhujbal, Swapnil V.
|
|
2014
|
79-80 |
C |
p. 142-153
12 p.
|
article
|
| 526 |
Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors – An update
|
Power, Erica A.
|
|
|
79-80 |
C |
p.
|
article
|
| 527 |
Drug delivery and epimorphic salamander-type mouse regeneration: A full parts and labor plan
|
Heber-Katz, Ellen
|
|
|
79-80 |
C |
p. 254-261
|
article
|
| 528 |
Drug delivery and tissue engineering to promote wound healing in the immunocompromised host: Current challenges and future directions
|
Tatara, Alexander M.
|
|
|
79-80 |
C |
p. 319-329
|
article
|
| 529 |
Drug delivery approaches for HuR-targeted therapy for lung cancer
|
Raguraman, Rajeswari
|
|
|
79-80 |
C |
p.
|
article
|
| 530 |
Drug delivery carriers with therapeutic functions
|
Cai, Shuting S.
|
|
|
79-80 |
C |
p.
|
article
|
| 531 |
Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: Illustration with the case of taxane therapeutics
|
Reddy, L. Harivardhan
|
|
2014
|
79-80 |
C |
p. 34-57
24 p.
|
article
|
| 532 |
Drug delivery devices for retinal diseases
|
Kaji, Hirokazu
|
|
2018
|
79-80 |
C |
p. 148-157
|
article
|
| 533 |
Drug delivery for metabolism targeted cancer immunotherapy
|
Khodaei, Taravat
|
|
|
79-80 |
C |
p.
|
article
|
| 534 |
Drug delivery progress in benign and malignant lesions of aging skin
|
Prow, Tarl W.
|
|
|
79-80 |
C |
p. 1
|
article
|
| 535 |
Drug delivery strategies for local immunomodulation in transplantation: Bridging the translational gap
|
Naaz, Afsana
|
|
|
79-80 |
C |
p.
|
article
|
| 536 |
Drug delivery strategies for management of women’s health issues in the upper genital tract
|
Patel, Sravan Kumar
|
|
|
79-80 |
C |
p.
|
article
|
| 537 |
Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity
|
Lai, Victoria
|
|
|
79-80 |
C |
p.
|
article
|
| 538 |
Drug delivery strategies in the therapy of inflammatory bowel disease
|
Lautenschläger, Christian
|
|
2014
|
79-80 |
C |
p. 58-76
19 p.
|
article
|
| 539 |
Drug delivery systems and materials for wound healing applications
|
Saghazadeh, Saghi
|
|
|
79-80 |
C |
p. 138-166
|
article
|
| 540 |
Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19
|
Brain, Danielle
|
|
|
79-80 |
C |
p.
|
article
|
| 541 |
Drug delivery systems for programmed and on-demand release
|
Davoodi, Pooya
|
|
2018
|
79-80 |
C |
p. 104-138
|
article
|
| 542 |
Drug delivery systems for treating neurodevelopmental disorders
|
Barak, Boaz
|
|
|
79-80 |
C |
p.
|
article
|
| 543 |
Drug delivery technologies for autoimmunity therapies
|
Thatte, Ajay S.
|
|
|
79-80 |
C |
p.
|
article
|
| 544 |
Drug delivery technologies for fetal, neonatal, and maternal therapy
|
Palanki, Rohan
|
|
|
79-80 |
C |
p.
|
article
|
| 545 |
Drug delivery to bony tissue
|
Balmayor, Elizabeth R.
|
|
2015
|
79-80 |
C |
p. 1-2
2 p.
|
article
|
| 546 |
Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases
|
He, Wei
|
|
|
79-80 |
C |
p. 15-40
|
article
|
| 547 |
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
|
Kreuter, Jörg
|
|
2014
|
79-80 |
C |
p. 2-14
13 p.
|
article
|
| 548 |
Drug delivery to the inflamed intestinal mucosa – targeting technologies and human cell culture models for better therapies of IBD
|
Hartwig, Olga
|
|
|
79-80 |
C |
p.
|
article
|
| 549 |
Drug delivery to the lens for the management of cataracts
|
Thrimawithana, Thilini R.
|
|
2018
|
79-80 |
C |
p. 185-194
|
article
|
| 550 |
Drug delivery to the pediatric upper airway
|
Ali Akbari Ghavimi, Soheila
|
|
|
79-80 |
C |
p. 168-189
|
article
|
| 551 |
Drug delivery using gold nanoparticles
|
Dykman, Lev
|
|
|
79-80 |
C |
p.
|
article
|
| 552 |
Drug development of lyso-thermosensitive liposomal doxorubicin: Combining hyperthermia and thermosensitive drug delivery
|
Borys, Nicholas
|
|
|
79-80 |
C |
p.
|
article
|
| 553 |
Drug discovery and therapeutic delivery for the treatment of B and T cell tumors
|
Stephenson, Regan
|
|
2017
|
79-80 |
C |
p. 285-300
|
article
|
| 554 |
Drug discovery through stem cell-based organoid models
|
Ranga, Adrian
|
|
2014
|
79-80 |
C |
p. 19-28
10 p.
|
article
|
| 555 |
Drug eluting antimicrobial vascular catheters: Progress and promise
|
Viola, George M.
|
|
2017
|
79-80 |
C |
p. 35-47
13 p.
|
article
|
| 556 |
Drug eluting devices for critically ill patients: Can we apply lessons learned from the treatment of peripheral artery disease?
|
Werner, Martin
|
|
2014
|
79-80 |
C |
p. 32-39
8 p.
|
article
|
| 557 |
Drug encapsulated polymeric microspheres for intracranial tumor therapy: A review of the literature
|
Floyd, J. Alaina
|
|
2015
|
79-80 |
C |
p. 23-37
15 p.
|
article
|
| 558 |
Drugging the lymphatic system: An emerging opportunity for cancer immunotherapy
|
Nakamura, Takashi
|
|
|
79-80 |
C |
p.
|
article
|
| 559 |
Drug release from in situ forming implants and advances in release testing
|
Wang, Xiaoyi
|
|
|
79-80 |
C |
p.
|
article
|
| 560 |
Drug supersaturation during formulation digestion, including real-time analytical approaches
|
Kuentz, Martin
|
|
2019
|
79-80 |
C |
p. 50-61
|
article
|
| 561 |
Drug targeting to myofibroblasts: Implications for fibrosis and cancer
|
Yazdani, Saleh
|
|
2017
|
79-80 |
C |
p. 101-116
|
article
|
| 562 |
Drug therapies and delivery mechanisms to treat perturbed skin wound healing
|
Chin, Jiah Shin
|
|
|
79-80 |
C |
p. 2-18
|
article
|
| 563 |
Dry powder inhalable formulations for anti-tubercular therapy
|
Parumasivam, Thaigarajan
|
|
2016
|
79-80 |
C |
p. 83-101
19 p.
|
article
|
| 564 |
Dry powder pharmaceutical biologics for inhalation therapy
|
Chang, Rachel Yoon Kyung
|
|
|
79-80 |
C |
p. 64-79
|
article
|
| 565 |
Dry powders for oral inhalation free of lactose carrier particles
|
Healy, Anne Marie
|
|
2014
|
79-80 |
C |
p. 32-52
21 p.
|
article
|
| 566 |
3D tissue-engineered model of Ewing's sarcoma
|
Lamhamedi-Cherradi, Salah-Eddine
|
|
2014
|
79-80 |
C |
p. 155-171
17 p.
|
article
|
| 567 |
Dual-controlled release system of drugs for bone regeneration
|
Kim, Yang-Hee
|
|
2015
|
79-80 |
C |
p. 28-40
13 p.
|
article
|
| 568 |
Dual delivery of biological therapeutics for multimodal and synergistic cancer therapies
|
Jang, Bora
|
|
2016
|
79-80 |
C |
p. 113-133
21 p.
|
article
|
| 569 |
Dual-functional drug liposomes in treatment of resistant cancers
|
Mu, Li-Min
|
|
2017
|
79-80 |
C |
p. 46-56
11 p.
|
article
|
| 570 |
Dye Doped Metal-Organic Frameworks for Enhanced Phototherapy
|
Zeng, Le
|
|
|
79-80 |
C |
p.
|
article
|
| 571 |
Dynamic nano-assemblies based on two-dimensional inorganic nanoparticles: Construction and preclinical demonstration
|
Sun, Luyao
|
|
|
79-80 |
C |
p.
|
article
|
| 572 |
Dynamic nanoassemblies for imaging and therapy of neurological disorders
|
Zhang, Lingxiao
|
|
|
79-80 |
C |
p.
|
article
|
| 573 |
Dynamic nanoassemblies of nanomaterials for cancer photomedicine
|
Jeong, Hayoon
|
|
|
79-80 |
C |
p.
|
article
|
| 574 |
Dynamic nanoassembly-based drug delivery system (DNDDS): Learning from nature
|
Hu, Xi
|
|
|
79-80 |
C |
p.
|
article
|
| 575 |
Dynamic reciprocity in cell–scaffold interactions
|
Mauney, Joshua R.
|
|
2015
|
79-80 |
C |
p. 77-85
9 p.
|
article
|
| 576 |
ECM and ECM-like materials — Biomaterials for applications in regenerative medicine and cancer therapy
|
Hinderer, Svenja
|
|
2016
|
79-80 |
C |
p. 260-269
10 p.
|
article
|
| 577 |
Editorial
|
Hou, Tingjun
|
|
2015
|
79-80 |
C |
p. 1-
1 p.
|
article
|
| 578 |
Editorial: Advanced Liposome Research
|
Harashima, Hideyoshi
|
|
|
79-80 |
C |
p. 1
|
article
|
| 579 |
Editorial: Advanced strategies to bridge the gap between inflammation and tissue regeneration
|
Rodrigues, Márcia T.
|
|
|
79-80 |
C |
p.
|
article
|
| 580 |
Editorial: Biomedical Engineering Approaches for HIV/AIDS Prophylaxis, Diagnostics and Therapy
|
Neves, José das
|
|
|
79-80 |
C |
p. 1-4
|
article
|
| 581 |
Editorial Board
|
|
|
2014
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 582 |
Editorial Board
|
|
|
2014
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 583 |
Editorial Board
|
|
|
2014
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 584 |
Editorial Board
|
|
|
2014
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 585 |
Editorial Board
|
|
|
2014
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 586 |
Editorial Board
|
|
|
2015
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 587 |
Editorial Board
|
|
|
2016
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 588 |
Editorial Board
|
|
|
2016
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 589 |
Editorial Board
|
|
|
2015
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 590 |
Editorial Board
|
|
|
2016
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 591 |
Editorial Board
|
|
|
2017
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 592 |
Editorial Board
|
|
|
2015
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 593 |
Editorial Board
|
|
|
2014
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 594 |
Editorial Board
|
|
|
2015
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 595 |
Editorial Board
|
|
|
2015
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 596 |
Editorial Board
|
|
|
2015
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 597 |
Editorial Board
|
|
|
2014
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 598 |
Editorial Board
|
|
|
2017
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 599 |
Editorial Board
|
|
|
2017
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 600 |
Editorial Board
|
|
|
2017
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 601 |
Editorial Board
|
|
|
2017
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 602 |
Editorial Board
|
|
|
2017
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 603 |
Editorial Board
|
|
|
2016
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 604 |
Editorial Board
|
|
|
2017
|
79-80 |
C |
p. ii
|
article
|
| 605 |
Editorial Board
|
|
|
2017
|
79-80 |
C |
p. ii
|
article
|
| 606 |
Editorial Board
|
|
|
2018
|
79-80 |
C |
p. ii
|
article
|
| 607 |
Editorial Board
|
|
|
2018
|
79-80 |
C |
p. ii
|
article
|
| 608 |
Editorial Board
|
|
|
2016
|
79-80 |
C |
p. ii
|
article
|
| 609 |
Editorial Board
|
|
|
2017
|
79-80 |
C |
p. ii
|
article
|
| 610 |
Editorial Board
|
|
|
2017
|
79-80 |
C |
p. ii
|
article
|
| 611 |
Editorial Board
|
|
|
2017
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 612 |
Editorial Board
|
|
|
2017
|
79-80 |
C |
p. ii
|
article
|
| 613 |
Editorial Board
|
|
|
2015
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 614 |
Editorial Board
|
|
|
2015
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 615 |
Editorial Board
|
|
|
2015
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 616 |
Editorial Board
|
|
|
2014
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 617 |
Editorial Board
|
|
|
2014
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 618 |
Editorial Board
|
|
|
2015
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 619 |
Editorial Board
|
|
|
2015
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 620 |
Editorial Board
|
|
|
2015
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 621 |
Editorial Board
|
|
|
2014
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 622 |
Editorial Board
|
|
|
2015
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 623 |
Editorial Board
|
|
|
2014
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 624 |
Editorial Board
|
|
|
2016
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 625 |
Editorial Board
|
|
|
2016
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 626 |
Editorial Board
|
|
|
2015
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 627 |
Editorial Board
|
|
|
2016
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 628 |
Editorial Board
|
|
|
2018
|
79-80 |
C |
p. ii
|
article
|
| 629 |
Editorial Board
|
|
|
2018
|
79-80 |
C |
p. ii
|
article
|
| 630 |
Editorial Board
|
|
|
2018
|
79-80 |
C |
p. ii
|
article
|
| 631 |
Editorial Board
|
|
|
2018
|
79-80 |
C |
p. ii
|
article
|
| 632 |
Editorial Board
|
|
|
2018
|
79-80 |
C |
p. ii
|
article
|
| 633 |
Editorial board
|
|
|
2019
|
79-80 |
C |
p. ii
|
article
|
| 634 |
Editorial Board
|
|
|
2019
|
79-80 |
C |
p. ii
|
article
|
| 635 |
Editorial Board
|
|
|
2018
|
79-80 |
C |
p. ii
|
article
|
| 636 |
Editorial Board
|
|
|
2018
|
79-80 |
C |
p. ii
|
article
|
| 637 |
Editorial Board
|
|
|
2019
|
79-80 |
C |
p. ii
|
article
|
| 638 |
Editorial Board
|
|
|
2019
|
79-80 |
C |
p. ii
|
article
|
| 639 |
Editorial Board
|
|
|
2019
|
79-80 |
C |
p. ii
|
article
|
| 640 |
Editorial Board
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 641 |
Editorial Board
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 642 |
Editorial Board
|
|
|
2019
|
79-80 |
C |
p. ii
|
article
|
| 643 |
Editorial Board
|
|
|
2019
|
79-80 |
C |
p. ii
|
article
|
| 644 |
Editorial Board
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 645 |
Editorial Board
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 646 |
Editorial Board
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 647 |
Editorial Board
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 648 |
Editorial Board
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 649 |
Editorial Board
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 650 |
Editorial board
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 651 |
Editorial Board
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 652 |
Editorial Board
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 653 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 654 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 655 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 656 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 657 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 658 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 659 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 660 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 661 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 662 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 663 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 664 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 665 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 666 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 667 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 668 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 669 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 670 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 671 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 672 |
Editorial Board
|
|
|
|
79-80 |
C |
p.
|
article
|
| 673 |
Editorial Board Members
|
|
|
2017
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 674 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 675 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 676 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 677 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 678 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 679 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 680 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 681 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 682 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 683 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 684 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 685 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 686 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 687 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 688 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 689 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 690 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 691 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 692 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 693 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 694 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 695 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 696 |
Editorial board members
|
|
|
2017
|
79-80 |
C |
p. ii
|
article
|
| 697 |
Editorial board members
|
|
|
2018
|
79-80 |
C |
p. ii
|
article
|
| 698 |
Editorial board members
|
|
|
2018
|
79-80 |
C |
p. ii
|
article
|
| 699 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 700 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 701 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 702 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 703 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 704 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 705 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 706 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 707 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 708 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 709 |
Editorial board members
|
|
|
|
79-80 |
C |
p. ii
|
article
|
| 710 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 711 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 712 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 713 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 714 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 715 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 716 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 717 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 718 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 719 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 720 |
Editorial board members
|
|
|
|
79-80 |
C |
p.
|
article
|
| 721 |
Editorial: Drug delivery in older people – unique challenges and important opportunities
|
McLachlan, Andrew J.
|
|
2018
|
79-80 |
C |
p. 1-2
|
article
|
| 722 |
Editorial: Drug Nanoparticles and Nano-Cocrystals: From Production and Characterization to Clinical Translation
|
Sosnik, Alejandro
|
|
2018
|
79-80 |
C |
p. 1-2
|
article
|
| 723 |
Editorial Editorial
|
|
|
2014
|
79-80 |
C |
p. ii-
1 p.
|
article
|
| 724 |
Editorial: Editors’ Collection 2016
|
Ghandehari, Hamidreza
|
|
2017
|
79-80 |
C |
p. 1-
1 p.
|
article
|
| 725 |
Editorial/Preface
|
Ling, Daishun
|
|
|
79-80 |
C |
p.
|
article
|
| 726 |
Editorial: Subcellular organelle-targeting of nanomaterials for enhancing therapeutic effectiveness
|
Youn, Yu Seok
|
|
|
79-80 |
C |
p.
|
article
|
| 727 |
Editorial: Super-resolution imaging of sub-cellular dynamics of drug molecules
|
Chen, Qixin
|
|
|
79-80 |
C |
p.
|
article
|
| 728 |
Editorial: Tissue engineering of the heart
|
Radisic, Milica
|
|
2016
|
79-80 |
C |
p. 1-2
2 p.
|
article
|
| 729 |
Editorial to ‘Biological Barriers to Drug Delivery’
|
Kumar, M.N.V. Ravi
|
|
|
79-80 |
C |
p.
|
article
|
| 730 |
Editorial to “Journey into the immunological properties of engineered nanomaterials: There and back again”
|
Dobrovolskaia, Marina A.
|
|
|
79-80 |
C |
p.
|
article
|
| 731 |
Editorial to “Molecular engineering of biomaterials programmed to operate in living systems”
|
Afonin, Kirill A.
|
|
|
79-80 |
C |
p.
|
article
|
| 732 |
Effective use of transdermal drug delivery in children
|
Delgado-Charro, M. Begoña
|
|
2014
|
79-80 |
C |
p. 63-82
20 p.
|
article
|
| 733 |
Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers
|
Zhao, Zongmin
|
|
|
79-80 |
C |
p. 3-21
|
article
|
| 734 |
Effects of Klotho on fibrosis and cancer: A renal focus on mechanisms and therapeutic strategies
|
Mencke, Rik
|
|
2017
|
79-80 |
C |
p. 85-100
|
article
|
| 735 |
Effects of nanoparticle deformability on multiscale biotransport
|
Gadalla, Hytham H.
|
|
|
79-80 |
C |
p.
|
article
|
| 736 |
Efficacy and safety concerns over the use of mucus modulating agents for drug delivery using nanoscale systems
|
Chater, Peter I.
|
|
2018
|
79-80 |
C |
p. 184-192
|
article
|
| 737 |
Elastin-like polypeptides in drug delivery
|
Rodríguez-Cabello, José Carlos
|
|
2016
|
79-80 |
C |
p. 85-100
16 p.
|
article
|
| 738 |
Electrical and mechanical stimulation of cardiac cells and tissue constructs
|
Stoppel, Whitney L.
|
|
2016
|
79-80 |
C |
p. 135-155
21 p.
|
article
|
| 739 |
Electrically conductive nanomaterials for cardiac tissue engineering
|
Ashtari, Khadijeh
|
|
|
79-80 |
C |
p. 162-179
|
article
|
| 740 |
Electric field-responsive nanoparticles and electric fields: physical, chemical, biological mechanisms and therapeutic prospects
|
Kolosnjaj-Tabi, Jelena
|
|
2019
|
79-80 |
C |
p. 56-67
|
article
|
| 741 |
Electroactive biomaterials: Vehicles for controlled delivery of therapeutic agents for drug delivery and tissue regeneration
|
Tandon, Biranche
|
|
|
79-80 |
C |
p. 148-168
|
article
|
| 742 |
Electroactive material-based biosensors for detection and drug delivery
|
Olvera, Dinorath
|
|
|
79-80 |
C |
p. 396-424
|
article
|
| 743 |
Electrohydrodynamic atomisation driven design and engineering of opportunistic particulate systems for applications in drug delivery, therapeutics and pharmaceutics
|
Ali, Amna
|
|
|
79-80 |
C |
p.
|
article
|
| 744 |
Electrohydrodynamic atomization and spray-drying for the production of pure drug nanocrystals and co-crystals
|
Sverdlov Arzi, Roni
|
|
2018
|
79-80 |
C |
p. 79-100
|
article
|
| 745 |
Electrospinning: An enabling nanotechnology platform for drug delivery and regenerative medicine
|
Chen, Shixuan
|
|
2018
|
79-80 |
C |
p. 188-213
|
article
|
| 746 |
Elongated self-assembled nanocarriers: From molecular organization to therapeutic applications
|
Mougin, Julie
|
|
|
79-80 |
C |
p. 127-147
|
article
|
| 747 |
Emergence of multidrug-resistant bacteria: important role of macromolecules and drug delivery systems
|
Yang, Yi Yan
|
|
2014
|
79-80 |
C |
p. 1-2
2 p.
|
article
|
| 748 |
Emerging aerosol drug delivery strategies: From bench to clinic
|
Rubin, Bruce K.
|
|
2014
|
79-80 |
C |
p. 141-148
8 p.
|
article
|
| 749 |
Emerging antibiotic alternatives: From antimicrobial peptides to bacteriophage therapies
|
Leung, Sharon Shui Yee
|
|
|
79-80 |
C |
p.
|
article
|
| 750 |
Emerging delivery approaches for targeted pulmonary fibrosis treatment
|
Diwan, Rimpy
|
|
|
79-80 |
C |
p.
|
article
|
| 751 |
Emerging 3D printing technologies for drug delivery devices: Current status and future perspective
|
Wang, Jiawei
|
|
|
79-80 |
C |
p. 294-316
|
article
|
| 752 |
Emerging drug delivery systems with traditional routes – A roadmap to chronic inflammatory diseases
|
Min, Kiyoon
|
|
|
79-80 |
C |
p.
|
article
|
| 753 |
Emerging hyperthermia applications for pediatric oncology
|
Tydings, Caitlin
|
|
|
79-80 |
C |
p. 157-167
|
article
|
| 754 |
Emerging inhalation aerosol devices and strategies: Where are we headed?
|
Zhou, Qi (Tony)
|
|
2014
|
79-80 |
C |
p. 3-17
15 p.
|
article
|
| 755 |
Emerging innate biological properties of nano-drug delivery systems: A focus on PAMAM dendrimers and their clinical potential
|
Kheraldine, Hadeel
|
|
|
79-80 |
C |
p.
|
article
|
| 756 |
Emerging Nanomedical Solutions for Angiogenesis Regulation
|
Blau, Rachel
|
|
2017
|
79-80 |
C |
p. 1-2
|
article
|
| 757 |
Emerging opportunities in bioconjugates of Elastin-like polypeptides with synthetic or natural polymers
|
Garanger, Elisabeth
|
|
|
79-80 |
C |
p.
|
article
|
| 758 |
Emerging plasmonic nanoparticles and their assemblies for cancer radiotherapy
|
Wu, Ying
|
|
|
79-80 |
C |
p.
|
article
|
| 759 |
Emerging strategies for delivering antiangiogenic therapies to primary and metastatic brain tumors
|
Askoxylakis, Vasileios
|
|
2017
|
79-80 |
C |
p. 159-174
|
article
|
| 760 |
Emerging strategies for nanomedicine in autoimmunity
|
Thatte, Ajay S.
|
|
|
79-80 |
C |
p.
|
article
|
| 761 |
Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics
|
Ang, Melgious Jin Yan
|
|
|
79-80 |
C |
p.
|
article
|
| 762 |
Emerging strategies of engineering retinal organoids and organoid-on-a-chip in modeling intraocular drug delivery: Current progress and future perspectives
|
Yu, Jiaheng
|
|
|
79-80 |
C |
p.
|
article
|
| 763 |
Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond
|
Abbaszadeh, Samin
|
|
|
79-80 |
C |
p.
|
article
|
| 764 |
Emerging targeted drug delivery strategies toward ovarian cancer
|
Wang, Zhe
|
|
|
79-80 |
C |
p.
|
article
|
| 765 |
Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care
|
Mani, Vigneshwaran
|
|
2014
|
79-80 |
C |
p. 105-117
13 p.
|
article
|
| 766 |
Emerging tools and targets for immune engineering and modulation
|
Rodell, Christopher B.
|
|
|
79-80 |
C |
p.
|
article
|
| 767 |
Emerging translational approaches for brain cancer therapeutics
|
Kim, Anthony J.
|
|
|
79-80 |
C |
p.
|
article
|
| 768 |
Emerging trends in inhaled drug delivery
|
Hickey, Anthony J.
|
|
|
79-80 |
C |
p. 63-70
|
article
|
| 769 |
Emerging Voices in Drug Delivery – Breaking Barriers (Issue 1)
|
Nguyen, Juliane
|
|
|
79-80 |
C |
p.
|
article
|
| 770 |
Emerging Voices in Drug Delivery – Harnessing and Modulating Complex Biological Systems (Issue 2)
|
Owen, Shawn C.
|
|
|
79-80 |
C |
p.
|
article
|
| 771 |
Enabling biodegradable functional biomaterials for the management of neurological disorders
|
Shan, Dingying
|
|
|
79-80 |
C |
p. 219-238
|
article
|
| 772 |
Enabling technologies for in situ biomanufacturing using probiotic yeast
|
Parker, William
|
|
|
79-80 |
C |
p.
|
article
|
| 773 |
Encapsulated cell therapy for neurodegenerative diseases: From promise to product
|
Emerich, Dwaine F.
|
|
2014
|
79-80 |
C |
p. 131-141
11 p.
|
article
|
| 774 |
Encapsulated islets for diabetes therapy: History, current progress, and critical issues requiring solution
|
Scharp, David W.
|
|
2014
|
79-80 |
C |
p. 35-73
39 p.
|
article
|
| 775 |
Encapsulation and immune protection for type 1 diabetes cell therapy
|
Kioulaphides, Sophia
|
|
|
79-80 |
C |
p.
|
article
|
| 776 |
Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers
|
Poluzzi, Chiara
|
|
2016
|
79-80 |
C |
p. 156-173
18 p.
|
article
|
| 777 |
Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy
|
Long, Qiong
|
|
|
79-80 |
C |
p.
|
article
|
| 778 |
Engineered cell and tissue models of pulmonary fibrosis
|
Sundarakrishnan, Aswin
|
|
|
79-80 |
C |
p. 78-94
|
article
|
| 779 |
Engineered delivery strategies for enhanced control of growth factor activities in wound healing
|
Niu, Yiming
|
|
2019
|
79-80 |
C |
p. 190-208
|
article
|
| 780 |
Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies
|
Tzatzalos, Evangeline
|
|
2016
|
79-80 |
C |
p. 234-244
11 p.
|
article
|
| 781 |
Engineered microbial systems for advanced drug delivery
|
Shen, Haosheng
|
|
|
79-80 |
C |
p.
|
article
|
| 782 |
Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses
|
Loessner, Daniela
|
|
2014
|
79-80 |
C |
p. 193-213
21 p.
|
article
|
| 783 |
Engineered nanomaterials that exploit blood-brain barrier dysfunction for delivery to the brain
|
Wu, Jason R.
|
|
|
79-80 |
C |
p.
|
article
|
| 784 |
Engineered nanoparticles mimicking cell membranes for toxin neutralization
|
Fang, Ronnie H.
|
|
2015
|
79-80 |
C |
p. 69-80
12 p.
|
article
|
| 785 |
Engineered organoids for biomedical applications
|
Roberto de Barros, Natan
|
|
|
79-80 |
C |
p.
|
article
|
| 786 |
Engineered tissues and strategies to overcome challenges in drug development
|
Khalil, Andrew S.
|
|
|
79-80 |
C |
p. 116-139
|
article
|
| 787 |
Engineering and loading therapeutic extracellular vesicles for clinical translation: A data reporting frame for comparability
|
Piffoux, Max
|
|
|
79-80 |
C |
p.
|
article
|
| 788 |
Engineering antigen-presenting cells for immunotherapy of autoimmunity
|
Smith, Clinton T.
|
|
|
79-80 |
C |
p.
|
article
|
| 789 |
Engineering bacterial membrane nanovesicles for improved therapies in infectious diseases and cancer
|
Gao, Jin
|
|
|
79-80 |
C |
p.
|
article
|
| 790 |
Engineering broadly neutralizing antibodies for HIV prevention and therapy
|
Hua, Casey K.
|
|
|
79-80 |
C |
p. 157-173
|
article
|
| 791 |
Engineering cells for precision drug delivery: New advances, clinical translation, and emerging strategies
|
Chao, Chih-Jia
|
|
|
79-80 |
C |
p.
|
article
|
| 792 |
Engineering challenges for brain tumor immunotherapy
|
Lyon, Johnathan G.
|
|
2017
|
79-80 |
C |
p. 19-32
|
article
|
| 793 |
Engineering complexity in human tissue models of cancer
|
Ronaldson-Bouchard, Kacey
|
|
|
79-80 |
C |
p.
|
article
|
| 794 |
Engineering interferons and interleukins for cancer immunotherapy
|
Holder, Patrick G.
|
|
|
79-80 |
C |
p.
|
article
|
| 795 |
Engineering in vitro immune-competent tissue models for testing and evaluation of therapeutics
|
Hammel, Jennifer H.
|
|
|
79-80 |
C |
p.
|
article
|
| 796 |
Engineering in vitro models of hepatofibrogenesis
|
Mazza, Giuseppe
|
|
2017
|
79-80 |
C |
p. 147-157
|
article
|
| 797 |
Engineering lymphocytes with RNAi
|
Ramishetti, Srinivas
|
|
2019
|
79-80 |
C |
p. 55-66
|
article
|
| 798 |
Engineering macromolecular nanocarriers for local delivery of gaseous signaling molecules
|
Hu, Jinming
|
|
|
79-80 |
C |
p.
|
article
|
| 799 |
Engineering metabolism to modulate immunity
|
Kapnick, Senta M.
|
|
|
79-80 |
C |
p.
|
article
|
| 800 |
Engineering nanomaterials to overcome the mucosal barrier by modulating surface properties
|
Wu, Lei
|
|
2018
|
79-80 |
C |
p. 150-163
|
article
|
| 801 |
Engineering nanoparticle toolkits for mRNA delivery
|
Sun, Bing
|
|
|
79-80 |
C |
p.
|
article
|
| 802 |
Engineering nanosystems to overcome barriers to cancer diagnosis and treatment
|
Alhaj-Suliman, Suhaila O.
|
|
|
79-80 |
C |
p.
|
article
|
| 803 |
Engineering of stimuli-responsive self-assembled biomimetic nanoparticles
|
Krishnan, Nishta
|
|
|
79-80 |
C |
p.
|
article
|
| 804 |
Engineering of tumor microenvironments
|
Hutmacher, Dietmar W.
|
|
2014
|
79-80 |
C |
p. 1-2
2 p.
|
article
|
| 805 |
Engineering self-assembled materials to study and direct immune function
|
Tostanoski, Lisa H.
|
|
2017
|
79-80 |
C |
p. 60-78
|
article
|
| 806 |
Engineering strategies to capture the biological and biophysical tumor microenvironment in vitro
|
Tan, Matthew L.
|
|
|
79-80 |
C |
p.
|
article
|
| 807 |
Engineering strategies to mimic the glioblastoma microenvironment
|
Rape, Andrew
|
|
2014
|
79-80 |
C |
p. 172-183
12 p.
|
article
|
| 808 |
Engineering stromal heterogeneity in cancer
|
Tang, Leon Jia Wei
|
|
|
79-80 |
C |
p.
|
article
|
| 809 |
Engineering the drug carrier biointerface to overcome biological barriers to drug delivery
|
Finbloom, Joel A.
|
|
|
79-80 |
C |
p. 89-108
|
article
|
| 810 |
Engineering the right formulation for enhanced drug delivery
|
Ke, Wei-Ren
|
|
|
79-80 |
C |
p.
|
article
|
| 811 |
Engineering Xenopus embryos for phenotypic drug discovery screening
|
Schmitt, Stefan M.
|
|
2014
|
79-80 |
C |
p. 225-246
22 p.
|
article
|
| 812 |
Enhanced antimicrobial activity through the combination of antimicrobial photodynamic therapy and low-frequency ultrasonic irradiation
|
Wang, Ying
|
|
|
79-80 |
C |
p.
|
article
|
| 813 |
Enhancing organoid technology with carbon-based nanomaterial biosensors: Advancements, challenges, and future directions
|
Rezaei, Zahra
|
|
|
79-80 |
C |
p.
|
article
|
| 814 |
Enhancing patient-level clinical data access to promote evidence-based practice and incentivize therapeutic innovation
|
Fortunato, Alice
|
|
2018
|
79-80 |
C |
p. 97-104
|
article
|
| 815 |
Enhancing the persistence of engineered biotherapeutics in the gut: Adhesion, glycan metabolism, and environmental resistance
|
Lee, Yujin
|
|
|
79-80 |
C |
p.
|
article
|
| 816 |
Enhancing therapeutic performance of personalized cancer vaccine via delivery vectors
|
Ye, Tong
|
|
|
79-80 |
C |
p.
|
article
|
| 817 |
Enhancing the therapeutic use of biofilm-dispersing enzymes with smart drug delivery systems
|
Thorn, Chelsea R.
|
|
|
79-80 |
C |
p.
|
article
|
| 818 |
Ensuring confidence in predictions: A scheme to assess the scientific validity of in silico models
|
Hewitt, Mark
|
|
2015
|
79-80 |
C |
p. 101-111
11 p.
|
article
|
| 819 |
Enzyme decorated drug carriers: Targeted swords to cleave and overcome the mucus barrier
|
Menzel, Claudia
|
|
2018
|
79-80 |
C |
p. 164-174
|
article
|
| 820 |
Enzyme prodrug therapies and therapeutic enzymes
|
Städler, Brigitte
|
|
2017
|
79-80 |
C |
p. 1
|
article
|
| 821 |
Enzymes as key features in therapeutic cell mimicry
|
Itel, Fabian
|
|
2017
|
79-80 |
C |
p. 94-108
|
article
|
| 822 |
Enzyme therapeutics for systemic detoxification
|
Liu, Yang
|
|
2015
|
79-80 |
C |
p. 24-39
16 p.
|
article
|
| 823 |
Epigenetic reprogramming in liver fibrosis and cancer
|
Wilson, Caroline L.
|
|
2017
|
79-80 |
C |
p. 124-132
|
article
|
| 824 |
Erratum to “Can microorganisms develop resistance against light based anti-infective agents?” [Adv. Drug Delivery Rev. 175 (2021) 113822]
|
Marasini, Sanjay
|
|
|
79-80 |
C |
p.
|
article
|
| 825 |
Erratum to ‘Silk fibroin for skin injury repair: Where do things stand?’. [Advanced Drug Delivery Reviews 153 (2020) 28-53]
|
Gholipourmalekabadi, Mazaher
|
|
|
79-80 |
C |
p. 190-196
|
article
|
| 826 |
Evaluation of transporters in drug development: Current status and contemporary issues
|
Lee, Sue-Chih
|
|
2017
|
79-80 |
C |
p. 100-118
19 p.
|
article
|
| 827 |
Evolution of nanomedicine formulations for targeted delivery and controlled release
|
Puri, Sanyogitta
|
|
|
79-80 |
C |
p.
|
article
|
| 828 |
Evolution of nanomedicines for the treatment of autoimmune disease: From vehicles for drug delivery to inducers of bystander immunoregulation
|
Yang, Yang
|
|
|
79-80 |
C |
p.
|
article
|
| 829 |
Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
|
Bhagchandani, Sachin
|
|
|
79-80 |
C |
p.
|
article
|
| 830 |
Exon skipping therapy for Duchenne muscular dystrophy
|
Kole, Ryszard
|
|
2015
|
79-80 |
C |
p. 104-107
4 p.
|
article
|
| 831 |
Exosome- and extracellular vesicle-based approaches for the treatment of lysosomal storage disorders
|
Lu, Biao
|
|
|
79-80 |
C |
p.
|
article
|
| 832 |
Exosomes and GPI-anchored proteins: Judicious pairs for investigating biomarkers from body fluids
|
Vidal, Michel
|
|
|
79-80 |
C |
p. 110-123
|
article
|
| 833 |
Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs)
|
Ke, Weina
|
|
|
79-80 |
C |
p.
|
article
|
| 834 |
Expanding the chemical repertoire of protein-based polymers for drug-delivery applications
|
Gueta, Osher
|
|
|
79-80 |
C |
p.
|
article
|
| 835 |
Experimental cocrystal screening and solution based scale-up cocrystallization methods
|
Malamatari, Maria
|
|
2017
|
79-80 |
C |
p. 162-177
16 p.
|
article
|
| 836 |
Experimental models of bone metastasis: Opportunities for the study of cancer dormancy
|
Chong Seow Khoon, Mark
|
|
2015
|
79-80 |
C |
p. 141-150
10 p.
|
article
|
| 837 |
Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges
|
Maisel, Katharina
|
|
2017
|
79-80 |
C |
p. 43-59
|
article
|
| 838 |
Exploiting nanoscale cooperativity for precision medicine
|
Wilhelm, Jonathan
|
|
|
79-80 |
C |
p. 63-72
|
article
|
| 839 |
Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments
|
McGivern, Jered V.
|
|
2014
|
79-80 |
C |
p. 170-178
9 p.
|
article
|
| 840 |
Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers
|
Fang, Jun
|
|
|
79-80 |
C |
p. 142-160
|
article
|
| 841 |
Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy
|
Figueroa-Espada, Christian G.
|
|
|
79-80 |
C |
p. 244-261
|
article
|
| 842 |
Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design
|
Kooijmans, Sander A.A.
|
|
|
79-80 |
C |
p. 252-278
|
article
|
| 843 |
Exploring the potential of cell-derived vesicles for transient delivery of gene editing payloads
|
Leandro, Kevin
|
|
|
79-80 |
C |
p.
|
article
|
| 844 |
Expression, activity and pharmacokinetic impact of ocular transporters
|
Vellonen, Kati-Sisko
|
|
2018
|
79-80 |
C |
p. 3-22
|
article
|
| 845 |
External physical and biochemical stimulation to enhance skeletal muscle bioengineering
|
Handschin, Christoph
|
|
2015
|
79-80 |
C |
p. 168-175
8 p.
|
article
|
| 846 |
External stimulus responsive inorganic nanomaterials for cancer theranostics
|
M., Sheikh Mohamed
|
|
2019
|
79-80 |
C |
p. 18-40
|
article
|
| 847 |
Extracellular matrix component signaling in cancer
|
Multhaupt, Hinke A.B.
|
|
2016
|
79-80 |
C |
p. 28-40
13 p.
|
article
|
| 848 |
Extracellular matrix-inspired growth factor delivery systems for bone regeneration
|
Martino, Mikaël M.
|
|
2015
|
79-80 |
C |
p. 41-52
12 p.
|
article
|
| 849 |
Extracellular matrix structure
|
Theocharis, Achilleas D.
|
|
2016
|
79-80 |
C |
p. 4-27
24 p.
|
article
|
| 850 |
Extracellular signaling molecules to promote fracture healing and bone regeneration
|
Hankenson, K.D.
|
|
2015
|
79-80 |
C |
p. 3-12
10 p.
|
article
|
| 851 |
Extracellular vesicle-associated lipids in central nervous system disorders
|
Vanherle, Sam
|
|
|
79-80 |
C |
p. 322-331
|
article
|
| 852 |
Extracellular vesicle-associated small heat shock proteins as therapeutic agents in neurodegenerative diseases and beyond
|
Van den Broek, Bram
|
|
|
79-80 |
C |
p.
|
article
|
| 853 |
Extracellular vesicles are key players in mesenchymal stem cells’ dual potential to regenerate and modulate the immune system
|
van Griensven, Martijn
|
|
|
79-80 |
C |
p.
|
article
|
| 854 |
Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies
|
Escudé Martinez de Castilla, Pol
|
|
|
79-80 |
C |
p.
|
article
|
| 855 |
Extracellular vesicles as antigen carriers for novel vaccination avenues
|
Mehanny, Mina
|
|
|
79-80 |
C |
p. 164-180
|
article
|
| 856 |
Extracellular vesicles as delivery systems at nano-/micro-scale
|
Fu, Peiwen
|
|
|
79-80 |
C |
p.
|
article
|
| 857 |
Extracellular vesicles as drug delivery systems: Why and how?
|
Elsharkasy, Omnia M.
|
|
|
79-80 |
C |
p. 332-343
|
article
|
| 858 |
Extracellular vesicles as modulators of wound healing
|
Cabral, Joana
|
|
|
79-80 |
C |
p. 394-406
|
article
|
| 859 |
Extracellular vesicles as novel assay tools to study cellular interactions of anti-infective compounds – A perspective
|
Richter, Robert
|
|
|
79-80 |
C |
p. 492-503
|
article
|
| 860 |
Extracellular vesicles for improved tumor accumulation and penetration
|
Bie, Nana
|
|
|
79-80 |
C |
p.
|
article
|
| 861 |
Extracellular vesicles for personalized medicine: The input of physically triggered production, loading and theranostic properties
|
Piffoux, Max
|
|
2019
|
79-80 |
C |
p. 247-258
|
article
|
| 862 |
Extracellular vesicles for the treatment of central nervous system diseases
|
Gratpain, Viridiane
|
|
|
79-80 |
C |
p. 535-552
|
article
|
| 863 |
Extracellular vesicles for tissue repair and regeneration: Evidence, challenges and opportunities
|
Nagelkerke, Anika
|
|
|
79-80 |
C |
p.
|
article
|
| 864 |
Extracellular vesicles from mesenchymal stromal cells: Therapeutic perspectives for targeting senescence in osteoarthritis
|
Boulestreau, Jérémy
|
|
|
79-80 |
C |
p.
|
article
|
| 865 |
Extracellular vesicles over adeno-associated viruses: Advantages and limitations as drug delivery platforms in precision medicine
|
Yom-Tov, Nataly
|
|
|
79-80 |
C |
p.
|
article
|
| 866 |
Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids
|
Bader, Johannes
|
|
|
79-80 |
C |
p.
|
article
|
| 867 |
Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines
|
Nakamura, Takashi
|
|
|
79-80 |
C |
p.
|
article
|
| 868 |
Fatty acid metabolism in the progression and resolution of CNS disorders
|
Bogie, Jeroen F.J.
|
|
|
79-80 |
C |
p. 198-213
|
article
|
| 869 |
Ferritin nanocage: A promising and designable multi-module platform for constructing dynamic nanoassembly-based drug nanocarrier
|
Zhang, Baoli
|
|
|
79-80 |
C |
p.
|
article
|
| 870 |
Fibrillin microfibrils and proteases, key integrators of fibrotic pathways
|
Zigrino, Paola
|
|
2019
|
79-80 |
C |
p. 3-16
|
article
|
| 871 |
Fibrin-based delivery strategies for acute and chronic wound healing
|
Heher, P.
|
|
|
79-80 |
C |
p. 134-147
|
article
|
| 872 |
Fibroblasts and extracellular matrix: Targeting and therapeutic tools in fibrosis and cancer
|
Prakash, Jai
|
|
2017
|
79-80 |
C |
p. 1-2
|
article
|
| 873 |
Fibronectin in development and wound healing
|
Patten, Jennifer
|
|
|
79-80 |
C |
p. 353-368
|
article
|
| 874 |
Fibronectin-targeted drug delivery in cancer
|
Kumra, Heena
|
|
2016
|
79-80 |
C |
p. 101-110
10 p.
|
article
|
| 875 |
Fibrosis imaging: Current concepts and future directions
|
Baues, Maike
|
|
2017
|
79-80 |
C |
p. 9-26
|
article
|
| 876 |
Fibrosis in tissue engineering and regenerative medicine: treat or trigger?
|
Fernández-Colino, Alicia
|
|
2019
|
79-80 |
C |
p. 17-36
|
article
|
| 877 |
Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities
|
Tuleta, Izabela
|
|
|
79-80 |
C |
p.
|
article
|
| 878 |
Fibrous scaffolds for building hearts and heart parts
|
Capulli, A.K.
|
|
2016
|
79-80 |
C |
p. 83-102
20 p.
|
article
|
| 879 |
Fit and forget: The future of dental implant therapy via nanotechnology
|
Gulati, Karan
|
|
|
79-80 |
C |
p.
|
article
|
| 880 |
Fluorescence anisotropy imaging in drug discovery
|
Vinegoni, Claudio
|
|
|
79-80 |
C |
p. 262-288
|
article
|
| 881 |
Fluorescence microscopic platforms imaging mitochondrial abnormalities in neurodegenerative diseases
|
Wang, Yicheng
|
|
|
79-80 |
C |
p.
|
article
|
| 882 |
Fluorescent imaging of cancerous tissues for targeted surgery
|
Bu, Lihong
|
|
2014
|
79-80 |
C |
p. 21-38
18 p.
|
article
|
| 883 |
Formulation and stabilization of recombinant protein based virus-like particle vaccines
|
Jain, Nishant K.
|
|
2015
|
79-80 |
C |
p. 42-55
14 p.
|
article
|
| 884 |
Formulation strategies for bacteriophages to target intracellular bacterial pathogens
|
Yan, Wei
|
|
|
79-80 |
C |
p.
|
article
|
| 885 |
Formulation strategies to improve the efficacy of intestinal permeation enhancers,
|
Maher, Sam
|
|
|
79-80 |
C |
p.
|
article
|
| 886 |
From bench to FDA to bedside: US regulatory trends for new stem cell therapies
|
Knoepfler, Paul S.
|
|
2015
|
79-80 |
C |
p. 192-196
5 p.
|
article
|
| 887 |
From cell-SELEX to tissue-SELEX for targeted drug delivery and aptamer nanomedicine
|
Wong, Ka-Ying
|
|
|
79-80 |
C |
p.
|
article
|
| 888 |
From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancer
|
Gonzales-Aloy, Estrella
|
|
|
79-80 |
C |
p.
|
article
|
| 889 |
From cells to subcellular organelles: Next-generation cancer therapy based on peptide self-assembly
|
Liu, Huayang
|
|
|
79-80 |
C |
p.
|
article
|
| 890 |
From concept to early clinical trials: 30 years of microbubble-based ultrasound-mediated drug delivery research
|
Bouakaz, Ayache
|
|
|
79-80 |
C |
p.
|
article
|
| 891 |
From in vitro to in vivo: A comprehensive guide to IVIVC development for long-acting therapeutics
|
Pastorin, Giorgia
|
|
|
79-80 |
C |
p.
|
article
|
| 892 |
From the gut to the blood–brain barrier: Novel approaches for the treatment and targeted delivery of therapeutics in Alzheimer’s disease
|
Nicolazzo, Joseph A.
|
|
|
79-80 |
C |
p.
|
article
|
| 893 |
Frontiers in the treatment of glioblastoma: Past, present and emerging
|
Janjua, Taskeen Iqbal
|
|
|
79-80 |
C |
p. 108-138
|
article
|
| 894 |
Functional antibody delivery: Advances in cellular manipulation
|
Koch, Kayla C.
|
|
|
79-80 |
C |
p.
|
article
|
| 895 |
Functional peptides for siRNA delivery
|
Tai, Wanyi
|
|
2017
|
79-80 |
C |
p. 157-168
12 p.
|
article
|
| 896 |
Functional regeneration at the blood-biomaterial interface
|
Ibrahim, Dina M.
|
|
|
79-80 |
C |
p.
|
article
|
| 897 |
Functional therapies for cutaneous wound repair in epidermolysis bullosa
|
Peking, Patricia
|
|
|
79-80 |
C |
p. 330-343
|
article
|
| 898 |
Fundamentals of fractional laser-assisted drug delivery: An in-depth guide to experimental methodology and data interpretation
|
Wenande, Emily
|
|
|
79-80 |
C |
p. 169-184
|
article
|
| 899 |
Fungal infections: Immune defense, immunotherapies and vaccines
|
Loh, Jia Tong
|
|
|
79-80 |
C |
p.
|
article
|
| 900 |
Fusobacterium nucleatum carcinogenesis and drug delivery interventions
|
Chen, Zhenzhen
|
|
|
79-80 |
C |
p.
|
article
|
| 901 |
“Future Directions” – Novel breakthrough developments in the fields of drug development & delivery, and regenerative medicine
|
Schenke-Layland, Katja
|
|
|
79-80 |
C |
p.
|
article
|
| 902 |
Gasotransmitter delivery via self-assembling peptides: Treating diseases with natural signaling gases
|
Qian, Yun
|
|
2017
|
79-80 |
C |
p. 137-156
20 p.
|
article
|
| 903 |
Gelatin-integrated carbon nanomaterials in nanomedicine: From biosensing and bioprinting to tissue engineering and other biomedical applications
|
Saeidirad, Mahdi
|
|
|
79-80 |
C |
p.
|
article
|
| 904 |
Gene and cell therapy for children — New medicines, new challenges?
|
Buckland, Karen F.
|
|
2014
|
79-80 |
C |
p. 162-169
8 p.
|
article
|
| 905 |
Gene- and RNAi-activated scaffolds for bone tissue engineering: Current progress and future directions
|
Laird, Noah Z.
|
|
|
79-80 |
C |
p. 613-627
|
article
|
| 906 |
Gene delivery nanoparticles to modulate angiogenesis
|
Kim, Jayoung
|
|
2017
|
79-80 |
C |
p. 20-43
|
article
|
| 907 |
Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses
|
Fachel, Flávia Nathiely Silveira
|
|
|
79-80 |
C |
p.
|
article
|
| 908 |
Gene editing therapeutics based on mRNA delivery
|
Popovitz, Juliana
|
|
|
79-80 |
C |
p.
|
article
|
| 909 |
Gene regulation in adult neural stem cells. Current challenges and possible applications
|
Encinas, Juan Manuel
|
|
2017
|
79-80 |
C |
p. 118-132
|
article
|
| 910 |
Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: Progress towards non-viral systems
|
Hakim, Antoine
|
|
|
79-80 |
C |
p.
|
article
|
| 911 |
Genome stability of programmed stem cell products
|
Martin, Ulrich
|
|
2017
|
79-80 |
C |
p. 108-117
|
article
|
| 912 |
Get out or die trying: Peptide- and protein-based endosomal escape of RNA therapeutics
|
Klipp, Alexander
|
|
|
79-80 |
C |
p.
|
article
|
| 913 |
Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS
|
Nair, Madhavan
|
|
|
79-80 |
C |
p. 202-217
|
article
|
| 914 |
GLP: A requirement in cell therapies - perspectives for the cardiovascular field
|
Müller-Ruch, Ulrike
|
|
|
79-80 |
C |
p. 96-104
|
article
|
| 915 |
Glycomacromolecules: Addressing challenges in drug delivery and therapeutic development
|
Stuart-Walker, Will
|
|
|
79-80 |
C |
p. 77-93
|
article
|
| 916 |
GO-based antibacterial composites: Application and design strategies
|
Hu, Chen
|
|
|
79-80 |
C |
p.
|
article
|
| 917 |
Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements
|
Her, Sohyoung
|
|
2017
|
79-80 |
C |
p. 84-101
18 p.
|
article
|
| 918 |
Growth factor and small molecule influence on urological tissue regeneration utilizing cell seeded scaffolds
|
Sharma, Arun K.
|
|
2015
|
79-80 |
C |
p. 86-92
7 p.
|
article
|
| 919 |
Guest Editorial Title: Nanomedicine: past, present, and future
|
Moon, James J.
|
|
2018
|
79-80 |
C |
p. 1-2
|
article
|
| 920 |
Guiding immunotherapy combinations: Who gets what?
|
Ferreira, Michelle N.
|
|
|
79-80 |
C |
p.
|
article
|
| 921 |
Gut-brain-immune interactions: exploring probiotics as a drug delivery platform for neurological disease
|
Gudi, Chinmayi R.
|
|
|
79-80 |
C |
p.
|
article
|
| 922 |
β-hairpin peptide hydrogels for package delivery
|
Worthington, Peter
|
|
2017
|
79-80 |
C |
p. 127-136
10 p.
|
article
|
| 923 |
Harnessing albumin as a carrier for cancer therapies
|
Hoogenboezem, Ella N.
|
|
2018
|
79-80 |
C |
p. 73-89
|
article
|
| 924 |
Harnessing anti-inflammatory pathways and macrophage nano delivery to treat inflammatory and fibrotic disorders
|
Zaid, Ahmad
|
|
|
79-80 |
C |
p.
|
article
|
| 925 |
Harnessing artificial intelligence for the next generation of 3D printed medicines
|
Elbadawi, Moe
|
|
|
79-80 |
C |
p.
|
article
|
| 926 |
Harnessing carbon nanomaterials for reactive oxygen species regulation: Insights into generation, scavenging, and sensing
|
Liu, Zhanpeng (Jim)
|
|
|
79-80 |
C |
p.
|
article
|
| 927 |
Harnessing cerebrospinal fluid circulation for drug delivery to brain tissues
|
Naseri Kouzehgarani, Ghazal
|
|
|
79-80 |
C |
p. 20-59
|
article
|
| 928 |
Harnessing epigenetic inhibitors: A promising approach for overcoming challenges in pancreatic ductal adenocarcinoma treatment
|
Maietta, Immacolata
|
|
|
79-80 |
C |
p.
|
article
|
| 929 |
Harnessing EV communication to restore antitumor immunity
|
Massaro, Crescenzo
|
|
|
79-80 |
C |
p.
|
article
|
| 930 |
Harnessing immune response using reactive oxygen Species-Generating/Eliminating inorganic biomaterials for disease treatment
|
Zhao, Caiyan
|
|
|
79-80 |
C |
p.
|
article
|
| 931 |
Harnessing macrophage plasticity for tissue regeneration
|
Smith, Tim D.
|
|
2017
|
79-80 |
C |
p. 193-205
|
article
|
| 932 |
Harnessing molecular recognition for localized drug delivery
|
Liu, Renjie
|
|
|
79-80 |
C |
p. 238-260
|
article
|
| 933 |
Heparin coatings for improving blood compatibility of medical devices
|
Biran, Roy
|
|
2017
|
79-80 |
C |
p. 12-23
12 p.
|
article
|
| 934 |
Hepatic stellate cells as key target in liver fibrosis
|
Higashi, Takaaki
|
|
2017
|
79-80 |
C |
p. 27-42
|
article
|
| 935 |
Hepatocellular carcinoma and microRNA: New perspectives on therapeutics and diagnostics
|
Yang, Ningning
|
|
2015
|
79-80 |
C |
p. 62-74
13 p.
|
article
|
| 936 |
Highly branched poly(β-amino ester)s for gene delivery in hereditary skin diseases
|
Zeng, Ming
|
|
|
79-80 |
C |
p.
|
article
|
| 937 |
High-throughput proteomics and AI for cancer biomarker discovery
|
Xiao, Qi
|
|
|
79-80 |
C |
p.
|
article
|
| 938 |
Hot or cold: Bioengineering immune contextures into in vitro patient-derived tumor models
|
Too, Nathaniel Sheng Hua
|
|
|
79-80 |
C |
p.
|
article
|
| 939 |
How can machine learning and multiscale modeling benefit ocular drug development?
|
Wang, Nannan
|
|
|
79-80 |
C |
p.
|
article
|
| 940 |
How does the pathophysiological context influence delivery of bone growth factors?
|
Yu, Xiaohua
|
|
2015
|
79-80 |
C |
p. 68-84
17 p.
|
article
|
| 941 |
How multi-organ microdevices can help foster drug development
|
Esch, Mandy B.
|
|
2014
|
79-80 |
C |
p. 158-169
12 p.
|
article
|
| 942 |
hPSC-based treatment of retinal diseases – Current progress and challenges
|
Ozaki, Atsuta
|
|
|
79-80 |
C |
p.
|
article
|
| 943 |
Human engineered heart tissue as a model system for drug testing
|
Eder, Alexandra
|
|
2016
|
79-80 |
C |
p. 214-224
11 p.
|
article
|
| 944 |
Human immunity in vitro — Solving immunogenicity and more
|
Giese, Christoph
|
|
2014
|
79-80 |
C |
p. 103-122
20 p.
|
article
|
| 945 |
Human ocular mucins: The endowed guardians of sight
|
Argüeso, Pablo
|
|
|
79-80 |
C |
p.
|
article
|
| 946 |
Human pathological basis of blood vessels and stromal tissue for nanotechnology
|
Nishihara, Hiroshi
|
|
2014
|
79-80 |
C |
p. 19-27
9 p.
|
article
|
| 947 |
Human pluripotent stem cell-based cardiac repair: Lessons learned and challenges ahead
|
Montague, E.Coulter
|
|
|
79-80 |
C |
p.
|
article
|
| 948 |
Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair
|
Hartman, Matthew E.
|
|
2016
|
79-80 |
C |
p. 3-17
15 p.
|
article
|
| 949 |
Human skin equivalents: Impaired barrier function in relation to the lipid and protein properties of the stratum corneum
|
Bouwstra, Joke A.
|
|
|
79-80 |
C |
p.
|
article
|
| 950 |
HuR as a molecular target for cancer therapeutics and immune-related disorders
|
Majumder, Mrinmoyee
|
|
|
79-80 |
C |
p.
|
article
|
| 951 |
Hurdles in translating science from lab to market in delivery systems for Cosmetics: An industrial perspective
|
Siqueira Andrade, Sheila
|
|
|
79-80 |
C |
p.
|
article
|
| 952 |
HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer models
|
Assoni, Giulia
|
|
|
79-80 |
C |
p.
|
article
|
| 953 |
Hyaluronan as a therapeutic target in human diseases
|
Liang, Jiurong
|
|
2016
|
79-80 |
C |
p. 186-203
18 p.
|
article
|
| 954 |
Hyaluronan as tunable drug delivery system
|
Passi, Alberto
|
|
2019
|
79-80 |
C |
p. 83-96
|
article
|
| 955 |
Hyaluronic acid for anticancer drug and nucleic acid delivery
|
Dosio, Franco
|
|
2016
|
79-80 |
C |
p. 204-236
33 p.
|
article
|
| 956 |
Hybrid drug nanocrystals
|
Lu, Yi
|
|
|
79-80 |
C |
p. 115-133
|
article
|
| 957 |
Hydrogel-based approaches to target hypersensitivity mechanisms underlying autoimmune disease
|
Kim, Kenneth M.
|
|
|
79-80 |
C |
p.
|
article
|
| 958 |
Hydrogels for therapeutic cardiovascular angiogenesis
|
Rufaihah, Abdul Jalil
|
|
2016
|
79-80 |
C |
p. 31-39
9 p.
|
article
|
| 959 |
Hydrogels to model 3D in vitro microenvironment of tumor vascularization
|
Song, Hyun-Ho Greco
|
|
2014
|
79-80 |
C |
p. 19-29
11 p.
|
article
|
| 960 |
Hydrogel vehicles for sequential delivery of protein drugs to promote vascular regeneration
|
Wei, Zhao
|
|
|
79-80 |
C |
p. 95-106
|
article
|
| 961 |
Hyperthermia and smart drug delivery systems for solid tumor therapy
|
Seynhaeve, A.L.B.
|
|
|
79-80 |
C |
p. 125-144
|
article
|
| 962 |
Hyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacy
|
Dunne, Michael
|
|
|
79-80 |
C |
p. 98-124
|
article
|
| 963 |
Illuminating RNA trafficking and functional delivery by extracellular vesicles
|
de Voogt, Willemijn S.
|
|
|
79-80 |
C |
p. 250-264
|
article
|
| 964 |
Image-guided drug delivery: Biomedical and imaging advances
|
Sofias, Alexandros Marios
|
|
|
79-80 |
C |
p.
|
article
|
| 965 |
Image-guided drug delivery in nanosystem-based cancer therapies
|
Priester, Marjolein I.
|
|
|
79-80 |
C |
p.
|
article
|
| 966 |
Image-guided drug delivery: Nanoparticle and probe advances
|
Guo, Bing
|
|
|
79-80 |
C |
p.
|
article
|
| 967 |
Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles
|
Phillips, William T.
|
|
2014
|
79-80 |
C |
p. 39-59
21 p.
|
article
|
| 968 |
Image-guided intratumoral immunotherapy: Developing a clinically practical technology
|
Som, Avik
|
|
|
79-80 |
C |
p.
|
article
|
| 969 |
Imaging and quantifying drug delivery in skin – Part 1: Autoradiography and mass spectrometry imaging
|
Grégoire, Sébastien
|
|
|
79-80 |
C |
p. 137-146
|
article
|
| 970 |
Imaging and quantifying drug delivery in skin – Part 2: Fluorescence andvibrational spectroscopic imaging methods
|
Pena, Ana-Maria
|
|
|
79-80 |
C |
p. 147-168
|
article
|
| 971 |
Imaging and therapeutic applications of persistent luminescence nanomaterials
|
Liu, Jianhua
|
|
2019
|
79-80 |
C |
p. 193-210
|
article
|
| 972 |
Imaging and therapeutic targeting of the tumor immune microenvironment with biologics
|
Arnouk, Sana
|
|
|
79-80 |
C |
p.
|
article
|
| 973 |
Imaging and therapy of diabetes: State of the art
|
Cai, Weibo
|
|
2019
|
79-80 |
C |
p. 1-2
|
article
|
| 974 |
Imaging drug delivery to the lungs: Methods and applications in oncology
|
Man, Francis
|
|
|
79-80 |
C |
p.
|
article
|
| 975 |
Imaging-guided delivery of RNAi for anticancer treatment
|
Wang, Junqing
|
|
2016
|
79-80 |
C |
p. 44-60
17 p.
|
article
|
| 976 |
Imaging-guided/improved diseases management for immune-strategies and beyond
|
Zhang, Tian
|
|
|
79-80 |
C |
p.
|
article
|
| 977 |
Imaging-guided targeted radionuclide tumor therapy: From concept to clinical translation
|
Sun, Juan
|
|
|
79-80 |
C |
p.
|
article
|
| 978 |
Imaging regional lung function: A critical tool for developing inhaled antimicrobial therapies
|
Dubsky, Stephen
|
|
2015
|
79-80 |
C |
p. 100-109
10 p.
|
article
|
| 979 |
Imaging technology of the lymphatic system
|
Polomska, Anna K.
|
|
|
79-80 |
C |
p. 294-311
|
article
|
| 980 |
Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior
|
Miller, Miles A.
|
|
2017
|
79-80 |
C |
p. 61-86
26 p.
|
article
|
| 981 |
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
|
Maulana, Tengku Ibrahim
|
|
|
79-80 |
C |
p. 281-305
|
article
|
| 982 |
Immunoengineering strategies to enhance vascularization and tissue regeneration
|
Zarubova, Jana
|
|
|
79-80 |
C |
p.
|
article
|
| 983 |
Immuno-engineering: The Next Frontier in Therapeutics Delivery
|
Singh, Ankur
|
|
2017
|
79-80 |
C |
p. 1-2
|
article
|
| 984 |
Immunological perspectives on spatial and temporal vaccine delivery
|
Zhu, Mingzhao
|
|
|
79-80 |
C |
p.
|
article
|
| 985 |
Immunology of carbohydrate-based vaccines
|
Khatun, Farjana
|
|
|
79-80 |
C |
p. 117-126
|
article
|
| 986 |
Immunophenotyping: Analytical approaches and role in preclinical development of nanomedicines
|
Newton, Hannah S.
|
|
|
79-80 |
C |
p.
|
article
|
| 987 |
Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery
|
Lansberry, T.R.
|
|
|
79-80 |
C |
p.
|
article
|
| 988 |
Immuno-regenerative biomaterials for in situ cardiovascular tissue engineering – Do patient characteristics warrant precision engineering?
|
de Kort, B.J.
|
|
|
79-80 |
C |
p.
|
article
|
| 989 |
Immunotherapies for locally aggressive cancers
|
Adams, Sarah C.
|
|
|
79-80 |
C |
p.
|
article
|
| 990 |
Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment
|
Zhang, Jie
|
|
|
79-80 |
C |
p.
|
article
|
| 991 |
Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics
|
Pan, Yijun
|
|
2018
|
79-80 |
C |
p. 62-74
|
article
|
| 992 |
Impact of particle elasticity on particle-based drug delivery systems
|
Anselmo, Aaron C.
|
|
2017
|
79-80 |
C |
p. 51-67
17 p.
|
article
|
| 993 |
Impact of the host microbiota on fungal infections: New possibilities for intervention?
|
Chow, Eve W.L.
|
|
|
79-80 |
C |
p.
|
article
|
| 994 |
Implantable Micro-Light-Emitting Diode (µLED)-based optogenetic interfaces toward human applications
|
Hee Lee, Jae
|
|
|
79-80 |
C |
p.
|
article
|
| 995 |
Implantable systems for neurological chronotherapy
|
Lee, Seung Ho
|
|
|
79-80 |
C |
p.
|
article
|
| 996 |
Implications and pitfalls for cancer diagnostics exploiting extracellular vesicles
|
Špilak, Ana
|
|
|
79-80 |
C |
p.
|
article
|
| 997 |
Implications of melanin binding in ocular drug delivery
|
Rimpelä, Anna-Kaisa
|
|
2018
|
79-80 |
C |
p. 23-43
|
article
|
| 998 |
Improving drug-like properties of insulin and GLP-1 via molecule design and formulation and improving diabetes management with device & drug delivery
|
Pechenov, Sergei
|
|
2017
|
79-80 |
C |
p. 106-122
17 p.
|
article
|
| 999 |
Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction
|
Chen, Wei
|
|
|
79-80 |
C |
p. 20-34
|
article
|
| 1000 |
Improving the efficacy of inhaled drugs for severe lung diseases: Emerging pulmonary delivery strategies
|
Ungaro, Francesca
|
|
2014
|
79-80 |
C |
p. 1-2
2 p.
|
article
|
Journal description